1 | S 90049 | - | - | - | - | [1] 6 6 💬 |
2 | S 90049 - F36 | - | - | - | - | [1] 6 6 💬 |
3 | S 90049 - F38 | - | - | - | - | [1] 6 6 💬 |
4 | S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide | - | - | - | - | [1] 46 46 💬 |
5 | S-1226 | - | - | - | - | [1] 299 299 💬 |
6 | S-adenosyl-L-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬 | - | - | [1] 93 93 💬 |
7 | S-adenosyl-methionine (SAMe) capsules | [2] Ademetionine Ademetionine, Methionine | [2] Methionine
Methionine
,
Ademetionine
💬 | - | - | [1] 93 93 💬 |
8 | S-Ketamin | - | - | - | - | [1] 298 298 💬 |
9 | S-ketamine | [2] Esketamine Esketamine, Ketamine | [2] Esketamine
Esketamine
,
Ketamine
💬 | [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 70 70 💬 |
10 | S-ketamine & midazolam | [3] Esketamine Esketamine, Ketamine, Midazolam | [3] Midazolam
Midazolam
,
Esketamine
,
Ketamine
💬 | [21] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [25] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 70 70 💬 |
11 | S-Warfarin | [2] (S)-Warfarin (S)-Warfarin, Warfarin | [1] Warfarin
Warfarin
💬 | [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 13 13 💬 |
12 | S.c. apomorphine | [1] Apomorphine Apomorphine | [1] Apomorphine
Apomorphine
💬 | [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
13 | S.c. injections of bovine intestinal Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 46 46 💬 |
14 | S1 | - | - | - | - | [1] 46 46 💬 |
15 | S38 | - | - | - | - | [1] 96 96 💬 |
16 | S78989 | - | - | - | - | [3] 41 41, 50, 56 💬 |
17 | S90049 | - | - | - | - | [1] 6 6 💬 |
18 | S95011 | - | - | - | - | [1] 53 53 💬 |
19 | S95011 concentrate for solution for infusion | - | - | - | - | [1] 53 53 💬 |
20 | SA | - | - | - | - | [4] 6 6, 30, 60, 298 💬 |
21 | SA-001 | - | - | - | - | [1] 298 298 💬 |
22 | SA001 High dose | - | - | - | - | [1] 53 53 💬 |
23 | SA001 Low dose | - | - | - | - | [1] 53 53 💬 |
24 | SA001 Mid dose | - | - | - | - | [1] 53 53 💬 |
25 | SA237 | - | - | - | - | [1] 13 13 💬 |
26 | SABRIL | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬 | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 145 145, 158 💬 |
27 | SABRIL 500 mg, granules for oral solution | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬 | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 158 158 💬 |
28 | Sabril granules for oral use | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬 | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬 |
29 | SABRIL SACHETS | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬 | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬 |
30 | Sabrilex | - | - | - | - | [1] 145 145 💬 |
31 | Sabril® | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬 | [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬 |
32 | Saccharomyces | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 💬 |
33 | Saccharomyces Boulardii Oral Tablet | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 💬 |
34 | Sacubitril | [1] Sacubitril Sacubitril | [1] Sacubitril
Sacubitril
💬 | [1] MME MME 💬 | [4] Alzheimer disease Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system 💬 | [2] 58 58, 222 💬 |
35 | SACUBITRIL VALSARTAN | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬 | [2] AGTR1 AGTR1, MME 💬 | [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬 |
36 | Sacubitril/Valsartan | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬 | [2] AGTR1 AGTR1, MME 💬 | [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬 |
37 | SAF-301 | - | - | - | - | [1] 19 19 💬 |
38 | Safety observation | - | - | - | - | [1] 6 6 💬 |
39 | Saffron | - | - | - | - | [1] 97 97 💬 |
40 | Saffron 100 | - | - | - | - | [1] 97 97 💬 |
41 | Saffron 50 | - | - | - | - | [1] 97 97 💬 |
42 | Saffron and Chamomile | [1] Chamomile Chamomile | [1] German chamomile flower
German chamomile flower
💬 | - | - | [1] 6 6 💬 |
43 | Saffron supplement for IBD | - | - | - | - | [1] 97 97 💬 |
44 | Saffron supplementation | - | - | - | - | [1] 301 301 💬 |
45 | Safinamida | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
46 | SAFINAMIDE | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬 |
47 | Safinamide (as add-on therapy) | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
48 | Safinamide + Levodopa | [2] Levodopa Levodopa, Safinamide | [2] Levodopa
Levodopa
,
Safinamide
💬 | [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 | [20] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
49 | Safinamide Mesilate | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
50 | SAFINAMIDE METANSOLFONATO | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬 |
51 | Safinamide metansolfonato (12 weeks) | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
52 | SAFINAMIDE METHANESULFONATE | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬 |
53 | Safinamide Methanesulfonate 100mg | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
54 | Safinamide Methanesulfonate 150mg | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
55 | Safinamide methansulfonate | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
56 | Safinamide, MAO-B inhibitor | [1] Safinamide Safinamide | [1] Safinamide
Safinamide
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
57 | Safinimide 50-100 mg/day | - | - | - | - | [1] 6 6 💬 |
58 | Sage | [1] Sage Sage | - | - | - | [1] 6 6 💬 |
59 | Sage leaf | [1] Sage Sage | - | - | - | [1] 6 6 💬 |
60 | SAGE-217 | - | - | - | - | [1] 6 6 💬 |
61 | SAGE-718 | - | - | - | - | [2] 6 6, 8 💬 |
62 | SAIT101 | - | - | - | - | [1] 46 46 💬 |
63 | SAIT101 (proposed rituximab biosimilar) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬 |
64 | SAIT101 (rituximab biosimilar) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬 |
65 | SAIZEN | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
66 | SAIZEN - 1 FLACONCINO POLV. 8 MG + 1 CARTUCCIA. SOLV. INSERITI IN UN DISPOSITIVO PER LA RICOSTITUZIONE | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
67 | Saizen 8mg click.easy powder for solution for injection | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
68 | Saizen 8mg click.easy power for solution for injection | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
69 | Saizen® | - | - | - | - | [1] 78 78 💬 |
70 | Saizen® solution for injection (referred as Saizen®) | - | - | - | - | [1] 78 78 💬 |
71 | Salazopyrin | - | - | - | - | [2] 46 46, 271 💬 |
72 | Salazopyrin EN | - | - | - | - | [2] 46 46, 271 💬 |
73 | Salazopyrin EN 500 mg enterotabletter | - | - | - | - | [1] 46 46 💬 |
74 | Salazopyrin EN-Tabs | - | - | - | - | [2] 46 46, 271 💬 |
75 | Salazopyrine | - | - | - | - | [1] 46 46 💬 |
76 | Salazosulfapyridine | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬 | - | - | [1] 46 46 💬 |
77 | Salbutamol | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 3 3, 11, 49, 85, 86, 111, 256, 299 💬 |
78 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet | [2] Salbutamol Salbutamol, Sulfate ion | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 💬 |
79 | Salbutamol 4Mg Tablet | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
80 | Salbutamol Only Product in Oral Dose Form | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 💬 |
81 | SALBUTAMOL SULFATE | [2] Salbutamol Salbutamol, Sulfate ion | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 💬 |
82 | SALBUTAMOL SULFATE PH. EUR. | [2] Salbutamol Salbutamol, Sulfate ion | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
83 | Salbutamol WZF 4 mg | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬 |
84 | Salbutamol-ratiopharm® N metered-dose aerosol inhaler | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
85 | Salbutamol-ratiopharm® N metereddose aerosol inhaler | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
86 | Salbutamolo | - | - | - | - | [1] 299 299 💬 |
87 | Salicylazosulfapyridine | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬 | - | - | [1] 271 271 💬 |
88 | Salicylic acid | [1] Salicylic acid Salicylic acid | [1] Salicylic acid
Salicylic acid
💬 | - | - | [1] 97 97 💬 |
89 | Saline | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [10] 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
90 | Saline 0.9% inhalation solution | - | - | - | - | [1] 299 299 💬 |
91 | Saline 0.9% NaCl | - | - | - | - | [1] 235 235 💬 |
92 | Saline Intranasal Delivery | - | - | - | - | [1] 6 6 💬 |
93 | Saline Nasal Mist | - | - | - | - | [1] 127 127 💬 |
94 | Saline solution | - | - | - | - | [4] 2 2, 34, 288, 299 💬 |
95 | Salirumab | - | - | - | - | [1] 46 46 💬 |
96 | Saliva sample | - | - | - | - | [1] 49 49 💬 |
97 | Salmeterol | [1] Salmeterol Salmeterol | [1] Salmeterol
Salmeterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
98 | Salmon | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [3] 96 96, 97, 225 💬 |
99 | Salofalk | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [2] 96 96, 97 💬 |
100 | Salofalk 1000mg Granu-Stix | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
101 | Salofalk 1000mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
102 | Salofalk 3g gastro-resistant prolonged-release granules | [2] Manganese citrate Manganese citrate, Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
103 | Salofalk 4g/60ml Klysma | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
104 | Salofalk 500 mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 96 96 💬 |
105 | Salofalk Granu-Stix 500 mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
106 | Salofalk® 1000mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
107 | Salofalk® 500 mg gastro-resistant tablet | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
108 | Salofalk® 500 mg tablets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
109 | Salofalk® 500mg | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
110 | Salofalk® 500mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
111 | Salsalate | [1] Salsalate Salsalate | [1] Salsalate
Salsalate
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 5 5 💬 |
112 | SAM | - | - | - | - | [1] 6 6 💬 |
113 | SAM-e | [1] Ademetionine Ademetionine | [1] Ademetionine
Ademetionine
💬 | - | - | [1] 6 6 💬 |
114 | SAMe | [1] Ademetionine Ademetionine | [1] Ademetionine
Ademetionine
💬 | - | - | [1] 93 93 💬 |
115 | Samsca | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬 | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 67 67, 72 💬 |
116 | Samsca 15 mg tablets | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬 | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬 |
117 | Samsca 30 mg tablets | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬 | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬 |
118 | SAMSCA 7.5 mg oral tablet | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬 | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 💬 |
119 | SAMSCA*10CPR 15MG | [1] Tolvaptan Tolvaptan | [1] Tolvaptan
Tolvaptan
💬 | [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 💬 |
120 | SAN-300 0.5 mg/kg QW | - | - | - | - | [1] 46 46 💬 |
121 | SAN-300 1.0 mg/kg QW | - | - | - | - | [1] 46 46 💬 |
122 | SAN-300 2.0 mg/kg QOW | - | - | - | - | [1] 46 46 💬 |
123 | SAN-300 4.0 mg/kg QOW | - | - | - | - | [1] 46 46 💬 |
124 | SAN-300 4.0 mg/kg QW | - | - | - | - | [1] 46 46 💬 |
125 | Sandimmum | - | - | - | - | [1] 97 97 💬 |
126 | Sandimmun | - | - | - | - | [2] 97 97, 226 💬 |
127 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1] 97 97 💬 |
128 | Sandimmun Neoral | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 60 60, 97, 226 💬 |
129 | SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
130 | SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
131 | SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
132 | SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬 |
133 | SANDIMMUN NEORAL*30CPS 100MG | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬 |
134 | SANDIMMUN NEORAL*50CPS 25MG | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬 |
135 | Sandimmun Optoral | - | - | - | - | [2] 53 53, 113 💬 |
136 | SANDINUM | - | - | - | - | [1] 97 97 💬 |
137 | Sandostatin LAR | [1] Octreotide Octreotide | [1] Octreotide
Octreotide
💬 | [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 84, 193, 227 💬 |
138 | Sandostatin LAR 20 mg | [1] Octreotide Octreotide | [1] Octreotide
Octreotide
💬 | [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 💬 |
139 | Sandostatina | - | - | - | - | [1] 67 67 💬 |
140 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 67 67 💬 |
141 | SANDOSTATINA LAR | - | - | - | - | [1] 67 67 💬 |
142 | Sandostatina Lar IM Fl 20mg +2F | - | - | - | - | [1] 67 67 💬 |
143 | Sandostatine | - | - | - | - | [1] 96 96 💬 |
144 | Sanqi | [1] Panax notoginseng root Panax notoginseng root | [1] Panax notoginseng root
Panax notoginseng root
💬 | - | - | [1] 222 222 💬 |
145 | Sapelizumab | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
146 | Sapelizumab (p-INN) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
147 | Sapropterin | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [3] 86 86, 124, 240 💬 |
148 | Sapropterin (Kuvan) | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
149 | SAPROPTERIN DIHYDROCHLORIDE | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
150 | Sapropterin dihydrochloride (6R-BH4) | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 86 86 💬 |
151 | Sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
152 | Sapropterin Dihydrocholoride | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
153 | SAPROPTERIN HYDROCHLORIDE | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
154 | Sapropterin, sapropterin dihydrochloride | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
155 | Sapropterin, sapropterin hydrochloride | [1] Sapropterin Sapropterin | [1] Sapropterin
Sapropterin
💬 | - | - | [1] 240 240 💬 |
156 | Sapropterindihydrochloride | - | - | - | - | [1] 240 240 💬 |
157 | Saproterin dihydrochloride | - | - | - | - | [1] 240 240 💬 |
158 | Saquinavir | [1] Saquinavir Saquinavir | [1] Saquinavir
Saquinavir
💬 | - | - | [2] 86 86, 265 💬 |
159 | Saquinavir and ritonavir | [2] Ritonavir Ritonavir, Saquinavir | [2] Ritonavir
Ritonavir
,
Saquinavir
💬 | - | - | [1] 86 86 💬 |
160 | Sar | - | - | - | - | [1] 46 46 💬 |
161 | SAR100842 | - | - | - | - | [2] 51 51, 85 💬 |
162 | SAR113244 | - | - | - | - | [1] 49 49 💬 |
163 | SAR153191 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 41 41, 46, 107, 271 💬 |
164 | SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 💬 |
165 | SAR156597 | - | - | - | - | [2] 51 51, 85 💬 |
166 | SAR231893 | - | - | - | - | [2] 51 51, 160 💬 |
167 | SAR236553 | - | - | - | - | [1] 79 79 💬 |
168 | SAR339375 | - | - | - | - | [1] 218 218 💬 |
169 | SAR339658 | - | - | - | - | [2] 13 13, 97 💬 |
170 | SAR402671, GZ402671 o GZ/SAR402671 | - | - | - | - | [2] 19 19, 67 💬 |
171 | SAR402671, GZ402671 or GZ / SAR402671 | - | - | - | - | [1] 19 19 💬 |
172 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | [3] 6 6, 19, 67 💬 |
173 | SAR421869 | - | - | - | - | [2] 90 90, 303 💬 |
174 | SAR422459 | - | - | - | - | [1] 301 301 💬 |
175 | SAR439459 | - | - | - | - | [1] 274 274 💬 |
176 | SAR441344 | - | - | - | - | [3] 13 13, 49, 53 💬 |
177 | SAR441344 IV | - | - | - | - | [2] 13 13, 49 💬 |
178 | SAR441344 SC | - | - | - | - | [2] 13 13, 49 💬 |
179 | SAR442168 | - | - | - | - | [2] 11 11, 13 💬 |
180 | SAR443122 | - | - | - | - | [1] 97 97 💬 |
181 | SAR443820 | - | - | - | - | [2] 2 2, 13 💬 |
182 | SAR444671 | - | - | - | - | [1] 61 61 💬 |
183 | SAR445088 | - | - | - | - | [1] 61 61 💬 |
184 | SAR445088 (formerly BIVV020) | - | - | - | - | [1] 14 14 💬 |
185 | SAR445088 (IV) | - | - | - | - | [1] 14 14 💬 |
186 | SAR445088 (SC) | - | - | - | - | [1] 14 14 💬 |
187 | SAR650984 | - | - | - | - | [1] 61 61 💬 |
188 | Saracatinab | - | - | - | - | [1] 85 85 💬 |
189 | Saracatinib | [1] Saracatinib Saracatinib | [1] Saracatinib
Saracatinib
💬 | [2] ABL1 ABL1, SRC 💬 | [49] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [3] 6 6, 89, 272 💬 |
190 | SARACATINIB DIFUMARATE | [1] Saracatinib Saracatinib | [1] Saracatinib
Saracatinib
💬 | [2] ABL1 ABL1, SRC 💬 | [49] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 272 272 💬 |
191 | Sarcosine | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 💬 |
192 | Sarcosine Capsule | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 💬 |
193 | Sargramostim | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬 | [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 💬 |
194 | Sargramostim (Leukine) | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬 | [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 96 96 💬 |
195 | SARILUMAB | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 41 41, 46, 84, 107, 271 💬 |
196 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA] | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬 |
197 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 84 84 💬 |
198 | Sarilumab SAR153191 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬 |
199 | Sarilumab SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 💬 |
200 | SARIZOTAN | [1] Sarizotan Sarizotan | - | - | - | [2] 6 6, 156 💬 |
201 | Sarizotan HC1 | [1] Sarizotan Sarizotan | - | - | - | [1] 6 6 💬 |
202 | Sarizotan HCl | [1] Sarizotan Sarizotan | - | - | - | [1] 6 6 💬 |
203 | Sarizotan Hydrochloride | [1] Sarizotan Sarizotan | - | - | - | [2] 6 6, 156 💬 |
204 | Saroglitazar | [1] Saroglitazar Saroglitazar | - | - | - | [1] 93 93 💬 |
205 | SAROGLITAZAR MAGNESIUM | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 💬 |
206 | Saroglitazar Magnesium 1 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 💬 |
207 | Saroglitazar Magnesium 2 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 💬 |
208 | Saroglitazar magnesium 4 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 💬 |
209 | SARS-COV-2 mRNA Vaccine | [2] CVnCoV CVnCoV, SARS-CoV-2 mRNA vaccine | - | - | - | [1] 13 13 💬 |
210 | SASS | - | - | - | - | [1] 36 36 💬 |
211 | Satavaptan | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬 |
212 | Satavaptan (SR121463) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬 |
213 | Satavaptan (SR121463B) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬 |
214 | Sativex | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 2 2, 13 💬 |
215 | Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
216 | Sativex Oromucosal Spray | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
217 | Sativex Oromucosal Spray (non-marketed) | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
218 | Sativex® | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬 | [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬 |
219 | SATRALIZUMAB | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 11 11, 13, 86 💬 |
220 | Satralizumab (120 mg/PFS with NSD) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
221 | Satralizumab (120 mg/vial) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
222 | Satralizumab (120mg/vial) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
223 | Satralizumab (Genetical Recombination) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 86 86 💬 |
224 | Satralizumab (r-INN) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
225 | Satralizumab (RO5333787/Enspryng /SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
226 | Satralizumab (RO5333787/Enspryng/SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
227 | Satralizumab (RO5333787/SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
228 | Satralizumab 120 mg | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
229 | Satrazlizumab (RO5333787/ Enspryng /SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬 |
230 | Sauerstoff | - | - | - | - | [2] 86 86, 88 💬 |
231 | Saxagliptin | [1] Saxagliptin Saxagliptin | [1] Saxagliptin
Saxagliptin
💬 | [1] DPP4 DPP4 💬 | [1] Protein digestion and absorption Protein digestion and absorption 💬 | [1] 299 299 💬 |
232 | Saxenda | [1] Liraglutide Liraglutide | [1] Liraglutide
Liraglutide
💬 | [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 193 193 💬 |
233 | SB 681323 | - | - | - | - | [1] 46 46 💬 |
234 | SB-240563 | - | - | - | - | [3] 44 44, 45, 98 💬 |
235 | SB-240563 (mepolizumab) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
💬 | [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 💬 |
236 | SB-318 | - | - | - | - | [1] 19 19 💬 |
237 | SB-47171 | - | - | - | - | [1] 19 19 💬 |
238 | SB-47898 | - | - | - | - | [1] 19 19 💬 |
239 | SB-497115 | - | - | - | - | [1] 63 63 💬 |
240 | SB-497115-GR | - | - | - | - | [1] 63 63 💬 |
241 | SB-497115-GR 12.5mg | - | - | - | - | [1] 63 63 💬 |
242 | SB-497115-GR 25mg | - | - | - | - | [1] 63 63 💬 |
243 | SB-497115-GR 50 mg | - | - | - | - | [1] 63 63 💬 |
244 | SB-509 | - | - | - | - | [1] 2 2 💬 |
245 | SB-656933 | - | - | - | - | [1] 97 97 💬 |
246 | SB-656933 Tablets | - | - | - | - | [2] 97 97, 299 💬 |
247 | SB-656933-AAA | - | - | - | - | [1] 299 299 💬 |
248 | SB-681323 | - | - | - | - | [1] 46 46 💬 |
249 | SB-681323 oral tablets | - | - | - | - | [1] 46 46 💬 |
250 | SB-681323 Tablets | - | - | - | - | [1] 46 46 💬 |
251 | SB-683699 | - | - | - | - | [1] 13 13 💬 |
252 | SB-913 | - | - | - | - | [1] 19 19 💬 |
253 | SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬 |
254 | SB-FIX | - | - | - | - | [1] 19 19 💬 |
255 | SB-IDUA | - | - | - | - | [1] 19 19 💬 |
256 | SB012 | - | - | - | - | [1] 97 97 💬 |
257 | SB12 (proposed eculizumab biosimilar) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
258 | SB2 | - | - | - | - | [1] 46 46 💬 |
259 | SB2 (infliximab biosimilar) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
260 | SB2 (proposed biosimilar to infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
261 | SB4 | - | - | - | - | [3] 46 46, 107, 271 💬 |
262 | SB4 (etanercept biosimilar) | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬 | [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 107, 271 💬 |
263 | SB4 (proposed biosimilar to etanercept) | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬 | [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
264 | SB497115 | - | - | - | - | [2] 60 60, 63 💬 |
265 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬 |
266 | SB5 (proposed biosimilar to adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
267 | SB656933 | - | - | - | - | [1] 299 299 💬 |
268 | SB683699 | - | - | - | - | [1] 13 13 💬 |
269 | SBC-102 | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
270 | SBC-102, recombinant human lysosomal acid lipase | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
271 | SBC-103 | - | - | - | - | [1] 19 19 💬 |
272 | SBI-087 | - | - | - | - | [2] 46 46, 49 💬 |
273 | SBT-020 | - | - | - | - | [1] 8 8 💬 |
274 | SBT101 | - | - | - | - | [1] 20 20 💬 |
275 | SC belimumab 200 mg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬 | [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬 |
276 | SC golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
277 | SC interferon beta-1a | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬 | [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬 |
278 | SC interferon beta-1b | [2] Human interferon beta Human interferon beta, Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬 | [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬 |
279 | SC Peginterferon beta-1a | [1] Peginterferon beta-1a Peginterferon beta-1a | [1] Peginterferon beta-1a
Peginterferon beta-1a
💬 | [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬 |
280 | Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) | [4] Amitriptyline Amitriptyline, Fluoxetine, Somatotropin, Tramadol | [3] Fluoxetine
Fluoxetine
,
Amitriptyline
,
Tramadol
💬 | [3] OPRM1 OPRM1, SLC6A2, SLC6A4 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 78 78 💬 |
281 | SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬 |
282 | SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬 |
283 | SC0062 high dose | - | - | - | - | [1] 66 66 💬 |
284 | SC0062 low dose | - | - | - | - | [1] 66 66 💬 |
285 | SC0062 medium dose | - | - | - | - | [1] 66 66 💬 |
286 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬 |
287 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬 |
288 | ScAAV8OTC | - | - | - | - | [1] 251 251 💬 |
289 | ScAAV9.CB.CLN6 | - | - | - | - | [1] 19 19 💬 |
290 | ScAAV9.U1A.hSGSH | - | - | - | - | [1] 19 19 💬 |
291 | ScAAV9.U1A.SGSH | - | - | - | - | [1] 19 19 💬 |
292 | ScAAV9.U7.ACCA | - | - | - | - | [1] 113 113 💬 |
293 | SCENESSE | [1] Afamelanotide Afamelanotide | [1] Afamelanotide
Afamelanotide
💬 | [1] MC1R MC1R 💬 | [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [3] 159 159, 161, 254 💬 |
294 | SCH 420814 | - | - | - | - | [1] 6 6 💬 |
295 | SCH 420814 10 mg | - | - | - | - | [1] 6 6 💬 |
296 | SCH 420814 100 mg | - | - | - | - | [1] 6 6 💬 |
297 | SCH 900050 | - | - | - | - | [1] 97 97 💬 |
298 | SCH 900259 | - | - | - | - | [1] 46 46 💬 |
299 | SCH 900800 | - | - | - | - | [1] 6 6 💬 |
300 | SCH-58235 | - | - | - | - | [1] 260 260 💬 |
301 | SCH420814 | - | - | - | - | [1] 6 6 💬 |
302 | SCH55700 | - | - | - | - | [1] 98 98 💬 |
303 | SCH900259 | - | - | - | - | [1] 46 46 💬 |
304 | Schisandra chinensis extract | - | - | - | - | [1] 84 84 💬 |
305 | SCID screening | - | - | - | - | [1] 65 65 💬 |
306 | SCIO-469 | - | - | - | - | [1] 46 46 💬 |
307 | SCLEROLYM | - | - | - | - | [1] 13 13 💬 |
308 | Sclerotherapy | - | - | - | - | [1] 227 227 💬 |
309 | SCM | - | - | - | - | [1] 13 13 💬 |
310 | SCM-010 | - | - | - | - | [1] 13 13 💬 |
311 | Scopolamine | [1] Scopolamine Scopolamine | [1] Scopolamine
Scopolamine
💬 | [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 💬 |
312 | Scopolamine, atropine, edaravone and dexmedetomidine | [4] Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | [4] Atropine
Atropine
,
Scopolamine
,
Dexmedetomidine
,
Edaravone
💬 | [8] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬 |
313 | SCP | - | - | - | - | [1] 6 6 💬 |
314 | SCRM001_TEVG | - | - | - | - | [1] 210 210 💬 |
315 | SCYX-7158 | - | - | - | - | [1] 65 65 💬 |
316 | SD-101 | - | - | - | - | [1] 36 36 💬 |
317 | SD-101 dermal cream (3%) | - | - | - | - | [1] 36 36 💬 |
318 | SD-101 Dermal Cream (6%) | - | - | - | - | [1] 36 36 💬 |
319 | SD-101-6.0 cream | - | - | - | - | [1] 36 36 💬 |
320 | SD-809 | - | - | - | - | [1] 8 8 💬 |
321 | SD-QIV | - | - | - | - | [1] 46 46 💬 |
322 | SE10599 | - | - | - | - | [1] 299 299 💬 |
323 | Seal oil | - | - | - | - | [1] 46 46 💬 |
324 | Search for exocrine pancreatic insufficiency at week 0 and 12 | - | - | - | - | [1] 96 96 💬 |
325 | Search for polymorphisms of RASA1 gene | - | - | - | - | [1] 281 281 💬 |
326 | Seasonal influenza vaccine | - | - | - | - | [2] 13 13, 46 💬 |
327 | Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | - | - | - | - | [1] 84 84 💬 |
328 | Seasonal Quadrivalent influenza vaccine | - | - | - | - | [1] 13 13 💬 |
329 | Sebelipasa Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
330 | Sebelipase Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
331 | Sebelipase alfa (SBC-102) | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
332 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
333 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
334 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬 | [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 💬 |
335 | Sebetralstat | - | - | - | - | [1] 65 65 💬 |
336 | Second-generation fumaric acid | [1] Fumaric acid Fumaric acid | [1] Fumaric acid
Fumaric acid
💬 | - | - | [1] 13 13 💬 |
337 | Secretin | [1] Secretin human Secretin human | - | - | - | [1] 298 298 💬 |
338 | Secukinmab | - | - | - | - | [1] 46 46 💬 |
339 | SECUKINUMAB | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [8] 13 13, 37, 41, 46, 107, 160, 269, 271 💬 |
340 | Secukinumab (150 mg) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
341 | Secukinumab (75 mg) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
342 | Secukinumab (AIN457) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 46 46 💬 |
343 | Secukinumab (AIN457) 150 mg s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
344 | Secukinumab 150 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬 |
345 | Secukinumab 150 mg (2 injections per dose | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 269 269 💬 |
346 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
347 | Secukinumab 150 mg/1 mL Solution for injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 37 37, 271 💬 |
348 | Secukinumab 150 mg/ml | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
349 | Secukinumab 150 milligram [Cosentyx] | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
350 | Secukinumab 150mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 💬 |
351 | Secukinumab 300 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬 |
352 | Secukinumab 300 mg, s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬 |
353 | Secukinumab 300mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 💬 |
354 | Secukinumab 75 mg/0.5 ml Solution for injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬 |
355 | Secukinumab Injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬 | [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 160 160 💬 |
356 | Sedatives/Hypnotics,Other | - | - | - | - | [1] 107 107 💬 |
357 | See D.3.9.3 'Other descriptive name' below | - | - | - | - | [1] 46 46 💬 |
358 | See Intervention Description) | - | - | - | - | [1] 13 13 💬 |
359 | SELADELPAR | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [2] 93 93, 94 💬 |
360 | Seladelpar 10 mg | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
361 | Seladelpar 10 mg Capsule | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
362 | Seladelpar 10 mg or less | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
363 | Seladelpar 5 mg | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
364 | Seladelpar 5 mg Capsule | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
365 | Seladelpar 5-10 mg | [1] Seladelpar Seladelpar | [1] Seladelpar
Seladelpar
💬 | [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬 |
366 | Selective Immunosuppressive agents | - | - | - | - | [1] 96 96 💬 |
367 | Selective Nerve Root Block | - | - | - | - | [1] 70 70 💬 |
368 | Selective Serotonin Uptake Inhibitors (SSRI) | [1] Serotonin Serotonin | - | - | - | [1] 2 2 💬 |
369 | SELEGILINE | [1] Selegiline Selegiline | [1] Selegiline
Selegiline
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
370 | Selegiline HCl 5 PCH | [1] Selegiline Selegiline | [1] Selegiline
Selegiline
💬 | [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
371 | Selenium | [1] Selenium Selenium | - | - | - | [4] 13 13, 96, 278, 298 💬 |
372 | SELEXIPAG | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [5] 51 51, 70, 84, 86, 88 💬 |
373 | Selexipag (Uptravi) | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
374 | Selexipag, ACT-293987 (NS-304) | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
375 | Seliciclib | [1] Seliciclib Seliciclib | - | - | - | [2] 75 75, 299 💬 |
376 | Selinexor | [1] Selinexor Selinexor | [1] Selinexor
Selinexor
💬 | [1] XPO1 XPO1 💬 | [5] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Nucleocytoplasmic transport, Ribosome biogenesis in eukaryotes, Viral life cycle - HIV-1 💬 | [1] 28 28 💬 |
377 | Selisistat | [1] Selisistat Selisistat | - | - | - | [1] 8 8 💬 |
378 | Selonsertib | [1] Selonsertib Selonsertib | [1] Selonsertib
Selonsertib
💬 | [1] MAP3K5 MAP3K5 💬 | [20] Alcoholic liver disease Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬 | [1] 86 86 💬 |
379 | Selumetinib | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
380 | Selumetinib (AZD6244 hyd sulfate) 25mg/m2 | [2] Selumetinib Selumetinib, Sulfate ion | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
381 | Selumetinib (AZD6244 hyd sulfate) 50mg/dose | [2] Selumetinib Selumetinib, Sulfate ion | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
382 | Selumetinib 10mg capsule | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
383 | Selumetinib 25mg capsule | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
384 | Selumetinib capsule formulation | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
385 | Selumetinib capsules 10mg | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
386 | Selumetinib capsules 25mg | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
387 | Selumetinib granule formulation | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
388 | Selumetinib granules in sprinkle capsules for opening 5 mg | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
389 | Selumetinib granules in sprinkle capsules for opening 7.5 mg | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
390 | Selumetinib hyd-sulfate | [2] Selumetinib Selumetinib, Sulfate ion | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
391 | Selumetinib Hyd-sulphate | [1] Selumetinib Selumetinib | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
392 | Selumetinib Sulfate | [2] Selumetinib Selumetinib, Sulfate ion | [1] Selumetinib
Selumetinib
💬 | [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
393 | Semaglutide | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬 | [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 💬 |
394 | Semapimod | [1] Semapimod Semapimod | - | - | - | [1] 96 96 💬 |
395 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | [1] 6 6 💬 |
396 | Semi-vegetarian diet | - | - | - | - | [1] 97 97 💬 |
397 | SEN0014196 | - | - | - | - | [1] 8 8 💬 |
398 | SEN0014196 (High Dose) | - | - | - | - | [1] 8 8 💬 |
399 | SEN0014196 (Low Dose) | - | - | - | - | [1] 8 8 💬 |
400 | Sendoxan | - | - | - | - | [2] 13 13, 43 💬 |
401 | Sendoxane | - | - | - | - | [1] 13 13 💬 |
402 | Senfrol monotherapy | - | - | - | - | [1] 6 6 💬 |
403 | Senna | [1] Senna leaf Senna leaf | [1] Senna leaf
Senna leaf
💬 | - | - | [1] 291 291 💬 |
404 | SEP-363856 | [1] SEP-363856 SEP-363856 | - | - | - | [1] 6 6 💬 |
405 | SEPTRIN | - | - | - | - | [1] 85 85 💬 |
406 | SER-214 | - | - | - | - | [1] 6 6 💬 |
407 | SER-287 | - | - | - | - | [1] 97 97 💬 |
408 | Seralutinib | - | - | - | - | [1] 86 86 💬 |
409 | Seretide | - | - | - | - | [1] 228 228 💬 |
410 | Sericare | - | - | - | - | [1] 36 36 💬 |
411 | Sericare® | - | - | - | - | [1] 36 36 💬 |
412 | Serine | [1] Serine Serine | [1] Serine
Serine
💬 | - | - | [4] 2 2, 6, 86, 96 💬 |
413 | Serlopitant | [1] Serlopitant Serlopitant | [1] Serlopitant
Serlopitant
💬 | [1] TACR1 TACR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 💬 |
414 | Serlopitant Tablet | [1] Serlopitant Serlopitant | [1] Serlopitant
Serlopitant
💬 | [1] TACR1 TACR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 💬 |
415 | Seroquel | - | - | - | - | [1] 6 6 💬 |
416 | Serostim®[somatropin (rDNA origin) for injection] | [1] Somatotropin Somatotropin | - | - | - | [1] 265 265 💬 |
417 | Serotonin | [1] Serotonin Serotonin | - | - | - | [1] 2 2 💬 |
418 | Sertraline | [1] Sertraline Sertraline | [1] Sertraline
Sertraline
💬 | [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 206 💬 |
419 | Serum albumin | [1] Albumin human Albumin human | [1] Albumin human
Albumin human
💬 | - | - | [1] 78 78 💬 |
420 | SERUM ALBUMINE 5% | - | - | - | - | [1] 96 96 💬 |
421 | Serum containing Avonex | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬 | [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬 |
422 | Serum Free Avonex | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬 | [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬 |
423 | Serum physiologique 0.9 % | - | - | - | - | [1] 96 96 💬 |
424 | Serum Zn | - | - | - | - | [1] 299 299 💬 |
425 | Sesame oil | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬 | - | - | [1] 3 3 💬 |
426 | SESAME OIL, REFINED | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬 | - | - | [1] 3 3 💬 |
427 | SETANAXIB | [1] Setanaxib Setanaxib | - | - | - | [1] 93 93 💬 |
428 | Setmelanotide | [1] Setmelanotide Setmelanotide | [1] Setmelanotide
Setmelanotide
💬 | [1] MC4R MC4R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 202 202, 265 💬 |
429 | SETRUSUMAB | [1] Setrusumab Setrusumab | - | - | - | [1] 274 274 💬 |
430 | Sevelamer | [1] Sevelamer Sevelamer | [1] Sevelamer
Sevelamer
💬 | - | - | [2] 235 235, 238 💬 |
431 | Sevoflurane | [1] Sevoflurane Sevoflurane | [1] Sevoflurane
Sevoflurane
💬 | - | - | [7] 6 6, 21, 22, 34, 98, 225, 296 💬 |
432 | Sevoflurane anesthetics | [1] Sevoflurane Sevoflurane | [1] Sevoflurane
Sevoflurane
💬 | - | - | [1] 296 296 💬 |
433 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | [1] 96 96 💬 |
434 | SF257 C59 | - | - | - | - | [1] 97 97 💬 |
435 | SF6 | - | - | - | - | [1] 299 299 💬 |
436 | Sfingomielina | - | - | - | - | [1] 79 79 💬 |
437 | SGLT2 inhibitor | - | - | - | - | [1] 218 218 💬 |
438 | SGT-001 | - | - | - | - | [1] 113 113 💬 |
439 | SH U 555 C | - | - | - | - | [1] 13 13 💬 |
440 | Sham | - | - | - | - | [1] 211 211 💬 |
441 | Sham O2 (medical air) | [2] Medical air Medical air, Oxygen | [1] Oxygen
Oxygen
💬 | - | - | [1] 86 86 💬 |
442 | Shingrix | [1] Varicella zoster vaccine (recombinant) Varicella zoster vaccine (recombinant) | - | - | - | [3] 46 46, 96, 97 💬 |
443 | SHMT1 polymorphism | - | - | - | - | [1] 6 6 💬 |
444 | Short Chain Fatty Acids (SCFA) Dietary Supplement | - | - | - | - | [1] 46 46 💬 |
445 | Short-acting Insulin (Actrapid) | - | - | - | - | [1] 299 299 💬 |
446 | Short-course Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬 |
447 | SHP 655 (BAX 930) | - | - | - | - | [1] 64 64 💬 |
448 | SHP611 | - | - | - | - | [1] 19 19 💬 |
449 | SHP647 | - | - | - | - | [2] 96 96, 97 💬 |
450 | SHP655 | - | - | - | - | [1] 64 64 💬 |
451 | SHP675 | - | - | - | - | [1] 19 19 💬 |
452 | SHR-1209 | - | - | - | - | [1] 79 79 💬 |
453 | SHR-1314 | - | - | - | - | [1] 271 271 💬 |
454 | SHR-1906 | - | - | - | - | [1] 85 85 💬 |
455 | SHR-2010 injection | - | - | - | - | [1] 66 66 💬 |
456 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 💬 |
457 | SHR0302 Tablets | - | - | - | - | [2] 46 46, 97 💬 |
458 | SI-722 | - | - | - | - | [1] 226 226 💬 |
459 | Sialic acid | - | - | - | - | [1] 30 30 💬 |
460 | Sialic acid (INN: aceneuramic acid) | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬 | - | - | [1] 30 30 💬 |
461 | Sialic acid, N-acetylneuraminic acid | - | - | - | - | [1] 30 30 💬 |
462 | Sibofimloc | [1] Sibofimloc Sibofimloc | [1] Sibofimloc
Sibofimloc
💬 | - | - | [1] 96 96 💬 |
463 | Sifalimumab | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬 | [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬 |
464 | Sifalimumab 1,200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬 | [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬 |
465 | Sifalimumab 200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬 | [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬 |
466 | Sifalimumab 600 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬 | [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬 |
467 | Sifol | - | - | - | - | [1] 6 6 💬 |
468 | SIFROL | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
469 | Sifrol 0,088 | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
470 | Sifrol 0,18 | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
471 | Sifrol 0,35 | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
472 | Sifrol 0,7 | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
473 | Sifrol, 0,35 mg Tablette | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
474 | Sifrol, 0,70 mg Tablette | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
475 | Sifrol, Mirapexin | [1] Pramipexole Pramipexole | [1] Pramipexole
Pramipexole
💬 | [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
476 | Sifrol® | - | - | - | - | [1] 6 6 💬 |
477 | SIGNIFOR | [1] Pasireotide Pasireotide | [1] Pasireotide
Pasireotide
💬 | [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 💬 |
478 | SILDENAF | - | - | - | - | [1] 86 86 💬 |
479 | Sildenafil | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
480 | Sildenafil (50 mg) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬 |
481 | Sildenafil (Acute-1 hour) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
482 | Sildenafil (as citrate) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
483 | Sildenafil (REVATIO) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
484 | Sildenafil (Revatio) 20 mg TID | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
485 | Sildenafil (Subchronic-4 weeks) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
486 | Sildenafil 20 mg tablets | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 💬 |
487 | Sildenafil 20mg | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬 |
488 | Sildenafil 20mg and Bosentan 62.5mg | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬 |
489 | Sildenafil 40mg oral capsule | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬 |
490 | Sildenafil and Losartan | [2] Losartan Losartan, Sildenafil | [2] Losartan
Losartan
,
Sildenafil
💬 | [2] AGTR1 AGTR1, PDE5A 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬 |
491 | Sildenafil by injection | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬 |
492 | Sildenafil citrate | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 💬 |
493 | Sildenafil citrate (UK-92,480) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
494 | Sildenafil Filmtabletten | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
495 | Sildenafil Oral Suspension | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 294 294 💬 |
496 | Sildenafil singly or in association with Bosentan | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
💬 | [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
497 | Sildenafil therapy | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬 |
498 | Sildenafil25 mg | - | - | - | - | [1] 17 17 💬 |
499 | SILDENAFILO | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
500 | Silikis 3µg/g Salbe | - | - | - | - | [1] 37 37 💬 |
501 | Silodosin | [1] Silodosin Silodosin | [1] Silodosin
Silodosin
💬 | [1] ADRA1A ADRA1A 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬 |
502 | Silodyx | [1] Silodosin Silodosin | [1] Silodosin
Silodosin
💬 | [1] ADRA1A ADRA1A 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬 |
503 | Siltuximab | [1] Siltuximab Siltuximab | [1] Siltuximab
Siltuximab
💬 | [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 28 28, 331 💬 |
504 | Silycus | - | - | - | - | [1] 75 75 💬 |
505 | Simethicone | [1] Simethicone Simethicone | [1] Simethicone
Simethicone
💬 | - | - | [2] 13 13, 96 💬 |
506 | SimpleCare | - | - | - | - | [1] 36 36 💬 |
507 | SIMPONI | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 97, 271 💬 |
508 | Simponi (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬 |
509 | SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
510 | Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte. | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
511 | SIMPONI 50 mg solución inyectable en pluma precargada | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
512 | Simponi® | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 97, 271 💬 |
513 | Simponi® (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬 |
514 | Simtuzimab | - | - | - | - | [1] 94 94 💬 |
515 | Simtuzumab | [1] Simtuzumab Simtuzumab | - | - | - | [2] 85 85, 94 💬 |
516 | Simulect | [1] Basiliximab Basiliximab | [1] Basiliximab
Basiliximab
💬 | [1] IL2RA IL2RA 💬 | [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 66 66, 97 💬 |
517 | SimvaHEXAL® 40 mg Filmtabletten | - | - | - | - | [1] 13 13 💬 |
518 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
519 | Simvastatin 20 mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 💬 |
520 | Simvastatin 20mg/5ml Oral Suspension | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 34 34 💬 |
521 | Simvastatin 40 mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 💬 |
522 | Simvastatin 40 mg film-coated tablets | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
523 | Simvastatin 40 mg tablets | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 💬 |
524 | Simvastatin 40mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 94 94 💬 |
525 | Simvastatin Alternova | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
526 | Simvastatin in relapsing remitting multiple sclerosis | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
527 | Simvastatin Susp. | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 310 310 💬 |
528 | Simvastatin treatment for 28 days | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 299 299 💬 |
529 | Simvastatin-ratiopharm | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬 |
530 | Simvastatin-ratiopharm® | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬 |
531 | Simvastatina | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
532 | Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
533 | Simvastatine | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 6 6, 13, 288 💬 |
534 | Simvastatine Sandoz 40 mg filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
535 | Simvastatine Sandoz 40mg deelbare filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬 |
536 | SIN ASIGNAR | - | - | - | - | [1] 299 299 💬 |
537 | SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1 | - | - | - | - | [1] 36 36 💬 |
538 | SIN RV-mediated COL7A1 corrected autologous skin equivalent | - | - | - | - | [1] 36 36 💬 |
539 | SINEMET | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
540 | Sinemet (carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
541 | Sinemet (comparator) | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
542 | Sinemet (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
543 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
544 | SINEMET 10-100 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
545 | SINEMET 100 mg + 25 mg compresse | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
546 | SINEMET 100 mg + 25 mg tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
547 | SINEMET 125 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
548 | Sinemet 125 mg | - | - | - | - | [1] 6 6 💬 |
549 | Sinemet 200mg/50mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
550 | SINEMET 25-100 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
551 | Sinemet 25-100 Oral Tablet | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬 | [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬 |
552 | SINEMET 25/100 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
553 | SINEMET CR | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
554 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | [3] Carbidopa Carbidopa, Levodopa, Manganese citrate | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
555 | Sinemet IR | - | - | - | - | [1] 6 6 💬 |
556 | SINEMET Plus | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
557 | Sinemet plus (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
558 | SINEMET*50CPR 100MG+25MG | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
559 | Sinemet-Plus Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
560 | Sinemet® | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
561 | Sinemet® 100/25 | - | - | - | - | [1] 6 6 💬 |
562 | Sinemet® 100/25 mg | - | - | - | - | [1] 6 6 💬 |
563 | Sinemet® controlled release (Carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
564 | Sinemet® CR | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
565 | Sinemet® CR 100/25 | - | - | - | - | [1] 6 6 💬 |
566 | SINEMET® Plus 25 mg/100 mg Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
567 | SINEMET®-Plus Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
568 | Sinemet®25-100 | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
569 | Single Dose | - | - | - | - | [2] 38 38, 162 💬 |
570 | Single dose C2N-8E12 | - | - | - | - | [1] 5 5 💬 |
571 | Single dose reduced | - | - | - | - | [1] 2 2 💬 |
572 | Single dose standard | - | - | - | - | [1] 2 2 💬 |
573 | Single dose-group A | - | - | - | - | [1] 97 97 💬 |
574 | Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) | - | - | - | - | [1] 28 28 💬 |
575 | Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre | - | - | - | - | [1] 65 65 💬 |
576 | Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy | - | - | - | - | [1] 79 79 💬 |
577 | Singulair | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬 | [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬 |
578 | Singulair (Montelukast Sodium) | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬 | [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬 |
579 | Sinomenine | [1] Sinomenine Sinomenine | - | - | - | [2] 46 46, 222 💬 |
580 | Sinvacor | - | - | - | - | [1] 51 51 💬 |
581 | SINVACOR*28CPR RIV 20MG | - | - | - | - | [1] 51 51 💬 |
582 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | [1] 13 13 💬 |
583 | Siponimid | - | - | - | - | [1] 50 50 💬 |
584 | Siponimob | - | - | - | - | [1] 13 13 💬 |
585 | SIPONIMOD | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬 |
586 | Siponimod 0,25 mg | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬 |
587 | Siponimod 0.25 mg tablet | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬 |
588 | Siponimod 0.5 mg tablet | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬 |
589 | Siponimod 1 mg | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬 |
590 | Siponimod 1 mg tablet | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬 |
591 | Siponimod 2 mg | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬 |
592 | Siponimod 2 mg tablet | [1] Siponimod Siponimod | [1] Siponimod
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬 |
593 | SIPONIMOD FUMARIC ACID | [2] Fumaric acid Fumaric acid, Siponimod | [2] Fumaric acid
Fumaric acid
,
Siponimod
💬 | [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬 |
594 | SIRIO*30CPR EFF 25MG+100MG | - | - | - | - | [1] 6 6 💬 |
595 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [35] 13 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331 💬 |
596 | Sirolimus (formerly known as Rapamycin) | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 35 35 💬 |
597 | Sirolimus (study drug)+ACE inhibitor + statin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 66 66 💬 |
598 | Sirolimus 0,1% crème | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 💬 |
599 | Sirolimus 0.2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 💬 |
600 | Sirolimus 0.4% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 💬 |
601 | Sirolimus 1mg/mL | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 💬 |
602 | Sirolimus 2 MG | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 17 17 💬 |
603 | Sirolimus 2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 💬 |
604 | Sirolimus and Hydroxychloroquine 200 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] Sirolimus
Sirolimus
,
Hydroxychloroquine
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 💬 |
605 | Sirolimus and Hydroxychloroquine 400 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] Sirolimus
Sirolimus
,
Hydroxychloroquine
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 💬 |
606 | Sirolimus Ointment | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 84 84 💬 |
607 | Sirolimus Oral Liquid Product 1mg/mL | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 💬 |
608 | Sirolimus Oral Product | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 89 89, 158 💬 |
609 | Sirolimus, 2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 💬 |
610 | Sirukuma | - | - | - | - | [1] 46 46 💬 |
611 | Sirukumab | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬 | [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 41 41, 46 💬 |
612 | Sirukumab 100 mg | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬 | [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬 |
613 | Sirukumab 50 mg | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬 | [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬 |
614 | Sitagliptin | [1] Sitagliptin Sitagliptin | [1] Sitagliptin
Sitagliptin
💬 | [1] DPP4 DPP4 💬 | [1] Protein digestion and absorption Protein digestion and absorption 💬 | [4] 6 6, 75, 233, 299 💬 |
615 | Sitagliptin and Metformin | [2] Metformin Metformin, Sitagliptin | [2] Metformin
Metformin
,
Sitagliptin
💬 | [3] DPP4 DPP4, PRKAA1, PRKAA2 💬 | [21] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 233 233 💬 |
616 | Sitaxentan | [1] Sitaxentan Sitaxentan | [1] Sitaxentan
Sitaxentan
💬 | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
617 | Sitaxentan sodium | [1] Sitaxentan Sitaxentan | [1] Sitaxentan
Sitaxentan
💬 | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
618 | Sitaxsentan | [1] Sitaxentan Sitaxentan | [1] Sitaxentan
Sitaxentan
💬 | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
619 | Sitaxsentan alone | [1] Sitaxentan Sitaxentan | [1] Sitaxentan
Sitaxentan
💬 | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
620 | Sitaxsentan and Sildenafil | [2] Sildenafil Sildenafil, Sitaxentan | [2] Sitaxentan
Sitaxentan
,
Sildenafil
💬 | [2] EDNRA EDNRA, PDE5A 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
621 | SITAXSENTAN SODIUM | [1] Sitaxentan Sitaxentan | [1] Sitaxentan
Sitaxentan
💬 | [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
622 | Site specific standard of care comparison | - | - | - | - | [2] 38 38, 39 💬 |
623 | SIVASTIN | - | - | - | - | [1] 15 15 💬 |
624 | Sivatin | - | - | - | - | [1] 13 13 💬 |
625 | Sivatin 40 mg film-coated tablets | - | - | - | - | [1] 13 13 💬 |
626 | Sivelestat | [1] Sivelestat Sivelestat | [1] Sivelestat
Sivelestat
💬 | [1] ELANE ELANE 💬 | [3] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [3] 13 13, 85, 96 💬 |
627 | SK&F101468 | - | - | - | - | [1] 6 6 💬 |
628 | SKF-101468A | - | - | - | - | [1] 6 6 💬 |
629 | SKI-606 | - | - | - | - | [1] 67 67 💬 |
630 | SKI-O-703 | - | - | - | - | [1] 46 46 💬 |
631 | SKI-O-703 capsule | - | - | - | - | [1] 46 46 💬 |
632 | Skin biopsy | - | - | - | - | [1] 6 6 💬 |
633 | Skincerity | - | - | - | - | [2] 34 34, 158 💬 |
634 | Skincerity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 💬 |
635 | Skinercity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬 | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 💬 |
636 | Sleep parameters | - | - | - | - | [1] 113 113 💬 |
637 | SLIT Amikacin | [1] Amikacin Amikacin | [1] Amikacin
Amikacin
💬 | - | - | [1] 299 299 💬 |
638 | SLIT(TM) Amikacin | [1] Amikacin Amikacin | [1] Amikacin
Amikacin
💬 | - | - | [1] 299 299 💬 |
639 | Slow Dose Titration Group of Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [1] Treprostinil
Treprostinil
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
640 | SLS | - | - | - | - | [1] 2 2 💬 |
641 | SLS-005 | - | - | - | - | [1] 2 2 💬 |
642 | SLS-005 Trehalose | [1] Trehalose Trehalose | - | - | - | [1] 2 2 💬 |
643 | SLV308 | - | - | - | - | [1] 6 6 💬 |
644 | SLV308 (mono) hydro | - | - | - | - | [1] 6 6 💬 |
645 | SLV308 (mono) hydrochlo | - | - | - | - | [1] 6 6 💬 |
646 | SLV308 (mono) hydrochlori | - | - | - | - | [1] 6 6 💬 |
647 | SLV308 (mono) hydrochloride | - | - | - | - | [1] 6 6 💬 |
648 | SLV308 (mono)hydrochloride | - | - | - | - | [1] 6 6 💬 |
649 | SLV308 hydrochloride | - | - | - | - | [1] 6 6 💬 |
650 | SLV308(mono)hydrochloride | - | - | - | - | [1] 6 6 💬 |
651 | SLV339 | - | - | - | - | [1] 298 298 💬 |
652 | SM03 | - | - | - | - | [1] 46 46 💬 |
653 | SM04646 | - | - | - | - | [1] 85 85 💬 |
654 | SM101 | - | - | - | - | [3] 49 49, 63, 66 💬 |
655 | SM101 20mg/mL | - | - | - | - | [1] 63 63 💬 |
656 | SM101 5mg/mL | - | - | - | - | [1] 63 63 💬 |
657 | SM934 | - | - | - | - | [1] 49 49 💬 |
658 | SMART | - | - | - | - | [1] 3 3 💬 |
659 | Smartject Device delivery of Golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬 |
660 | SMderpept | - | - | - | - | [1] 13 13 💬 |
661 | SMILAGENIN | [1] Smilagenin Smilagenin | - | - | - | [1] 6 6 💬 |
662 | Smofkabiven | [2] Medium-chain triglycerides Medium-chain triglycerides, Sodium glycerophosphate | [1] Sodium glycerophosphate
Sodium glycerophosphate
💬 | - | - | [1] 66 66 💬 |
663 | SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML | [2] Medium-chain triglycerides Medium-chain triglycerides, Sodium glycerophosphate | [1] Sodium glycerophosphate
Sodium glycerophosphate
💬 | - | - | [1] 66 66 💬 |
664 | SMOFLipid | [1] Medium-chain triglycerides Medium-chain triglycerides | - | - | - | [1] 96 96 💬 |
665 | Smoked Cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 💬 |
666 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 💬 |
667 | Smoking of cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [2] 96 96, 97 💬 |
668 | SMP-114 | - | - | - | - | [1] 46 46 💬 |
669 | SMT C1100 | - | - | - | - | [1] 113 113 💬 |
670 | SMT C1100 (F5 | - | - | - | - | [1] 113 113 💬 |
671 | SMT C1100 (F5) | - | - | - | - | [1] 113 113 💬 |
672 | SMT C1100 (F6 | - | - | - | - | [1] 113 113 💬 |
673 | SMT C1100 (F6) | - | - | - | - | [1] 113 113 💬 |
674 | SMX | - | - | - | - | [1] 299 299 💬 |
675 | SND 919 CL2 Y | - | - | - | - | [1] 6 6 💬 |
676 | SND 919 CL2Y | - | - | - | - | [1] 6 6 💬 |
677 | SNN0029 | - | - | - | - | [1] 2 2 💬 |
678 | SNN0029 infusion solution | - | - | - | - | [1] 2 2 💬 |
679 | SNN0031 | - | - | - | - | [1] 6 6 💬 |
680 | SNSP113 | - | - | - | - | [1] 299 299 💬 |
681 | SNT-MC17 | - | - | - | - | [1] 113 113 💬 |
682 | Sobetirome | [1] Sobetirome Sobetirome | [1] Sobetirome
Sobetirome
💬 | [1] THRB THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 💬 |
683 | Sobetirome (NV1205) | [1] Sobetirome Sobetirome | [1] Sobetirome
Sobetirome
💬 | [1] THRB THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 💬 |
684 | SOBI003 | - | - | - | - | [1] 19 19 💬 |
685 | SOC | - | - | - | - | [1] 47 47 💬 |
686 | SoC Therapy | - | - | - | - | [1] 171 171 💬 |
687 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬 | [2] NR3C1 NR3C1, PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬 |
688 | SODIO ASCORBATO DC.IT | - | - | - | - | [1] 10 10 💬 |
689 | Sodio phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 2 2 💬 |
690 | Sodio valproato | - | - | - | - | [1] 144 144 💬 |
691 | Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca | - | - | - | - | [1] 299 299 💬 |
692 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | [1] Pyrrolidine Pyrrolidine | - | - | - | [1] 97 97 💬 |
693 | Sodium 4-Phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 299 299 💬 |
694 | Sodium 4-Phenylbutyrate (4PBA) | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 299 299 💬 |
695 | Sodium acetate | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬 | - | - | [2] 81 81, 251 💬 |
696 | Sodium acetate (1-13C) | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬 | - | - | [1] 251 251 💬 |
697 | SODIUM ACID PYROPHOSPHATE | - | - | - | - | [1] 166 166 💬 |
698 | SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE | - | - | - | - | [1] 166 166 💬 |
699 | SODIUM ALGINATE | [1] Alginic acid Alginic acid | [1] Alginic acid
Alginic acid
💬 | - | - | [1] 299 299 💬 |
700 | Sodium aurothiomalate | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] Gold sodium thiomalate
Gold sodium thiomalate
💬 | - | - | [1] 46 46 💬 |
701 | Sodium aurothiomalate (intramuscular gold) | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] Gold sodium thiomalate
Gold sodium thiomalate
💬 | - | - | [1] 46 46 💬 |
702 | Sodium Bicarbonate | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬 | - | - | [1] 299 299 💬 |
703 | SODIUM BICARBONATE BP | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬 | - | - | [1] 299 299 💬 |
704 | Sodium Butyrate | [1] Butyric Acid Butyric Acid | - | - | - | [1] 46 46 💬 |
705 | Sodium butyrate and zinc oxide | [2] Butyric Acid Butyric Acid, Zinc oxide | [1] Zinc oxide
Zinc oxide
💬 | - | - | [1] 156 156 💬 |
706 | Sodium chlorid | - | - | - | - | [1] 13 13 💬 |
707 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [20] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
708 | Sodium chloride (7%) | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
709 | Sodium chloride (NaCl) | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 67 67 💬 |
710 | Sodium chloride 0,9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
711 | Sodium Chloride 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [2] 14 14, 227 💬 |
712 | Sodium chloride 6% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
713 | SODIUM CHLORIDE 7% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
714 | SODIUM CHLORIDE PH. EUR. | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
715 | Sodium Chloride solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [4] 11 11, 13, 51, 228 💬 |
716 | SODIUM CHLORIDE SOLUTION 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [4] 51 51, 60, 288, 299 💬 |
717 | Sodium Chloride Solvent | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 228 228 💬 |
718 | Sodium citrate | [1] Sodium citrate Sodium citrate | [2] Sodium citrate hydrate
Sodium citrate hydrate
,
Sodium citrate
💬 | - | - | [4] 67 67, 214, 215, 235 💬 |
719 | SODIUM CROMOGLICATE | [1] Cromoglicic acid Cromoglicic acid | [1] Cromoglicic acid
Cromoglicic acid
💬 | - | - | [1] 85 85 💬 |
720 | Sodium Ethanoate (1- 13 C) | [1] Acetic acid Acetic acid | [1] Acetic acid, glacial
Acetic acid, glacial
💬 | - | - | [1] 251 251 💬 |
721 | Sodium Ethanoate (1-13C) | [1] Acetic acid Acetic acid | [1] Acetic acid, glacial
Acetic acid, glacial
💬 | - | - | [1] 251 251 💬 |
722 | Sodium fluoride | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬 | - | - | [1] 51 51 💬 |
723 | Sodium fluoride 18F | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬 | - | - | [1] 51 51 💬 |
724 | Sodium Fusidate | [1] Fusidic acid Fusidic acid | [1] Fusidic acid
Fusidic acid
💬 | - | - | [1] 299 299 💬 |
725 | Sodium hyaluronate | [1] Hyaluronic acid Hyaluronic acid | [1] Hyaluronic acid
Hyaluronic acid
💬 | - | - | [2] 53 53, 97 💬 |
726 | Sodium iodide | [2] Iodide Iodide, Sodium iodide | [3] Sodium iodide
Sodium iodide
,
Sodium iodide I 123
,
Sodium iodide I 125
💬 | - | - | [1] 34 34 💬 |
727 | Sodium Nitrate | [2] Nitrate Nitrate, Sodium nitrate | [1] Nitric acid
Nitric acid
💬 | - | - | [2] 58 58, 113 💬 |
728 | Sodium Nitrate - double dose | [2] Nitrate Nitrate, Sodium nitrate | [1] Nitric acid
Nitric acid
💬 | - | - | [1] 113 113 💬 |
729 | SODIUM NITRITE | [1] Nitrite Nitrite | - | - | - | [1] 86 86 💬 |
730 | Sodium Nitrite Inhalation Solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 💬 |
731 | SODIUM NITROPRUSSIDE | [1] Nitroprusside Nitroprusside | - | - | - | [1] 51 51 💬 |
732 | Sodium Oxybate | [2] Sodium oxybate Sodium oxybate, gamma-Hydroxybutyric acid | [1] Sodium oxybate
Sodium oxybate
💬 | - | - | [2] 6 6, 149 💬 |
733 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [4] 2 2, 3, 8, 251 💬 |
734 | Sodium phenylbutyrate (NaPB) | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 3 3 💬 |
735 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | [3] Phosphate ion Phosphate ion, Polyethylene glycol, Rifaximin | [2] Rifaximin
Rifaximin
,
Polyethylene glycol 3350
💬 | - | - | [1] 6 6 💬 |
736 | Sodium Picosulfate, Magnesium Oxide and Citric Acid | [4] Citric acid Citric acid, Magnesium, Magnesium oxide, Picosulfuric acid | [2] Magnesium oxide
Magnesium oxide
,
Citric acid monohydrate
💬 | - | - | [1] 291 291 💬 |
737 | Sodium Picosulfate/Magnesium Citrate Laxative | [4] Magnesium Magnesium, Magnesium citrate, Picosulfuric acid, Polyethylene glycol | [2] Magnesium citrate
Magnesium citrate
,
Polyethylene glycol 3350
💬 | - | - | [1] 97 97 💬 |
738 | SODIUM PYRUVATE | - | - | - | - | [2] 2 2, 67 💬 |
739 | Sodium Pyruvate in 0.9% Sodium Chloride Solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 299 299 💬 |
740 | Sodium sulfate | [2] Sodium sulfate Sodium sulfate, Sulfate ion | [1] Sodium sulfate
Sodium sulfate
💬 | - | - | [1] 28 28 💬 |
741 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | [2] Dextrose, unspecified form Dextrose, unspecified form, Sildenafil | [1] Sildenafil
Sildenafil
💬 | [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
742 | Sodium Thiosulfate | - | - | - | - | [2] 50 50, 51 💬 |
743 | Sodium Thiosulfate 10% | - | - | - | - | [2] 50 50, 51 💬 |
744 | SODIUM THIOSULFATE PENTAHYDRATE | - | - | - | - | [2] 50 50, 51 💬 |
745 | Sodium Valproate | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [4] 2 2, 90, 102, 256 💬 |
746 | Sodium valproate 200 mg gastro-resistant tablets | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 💬 |
747 | Sodium Valproate 200Mg E/C Tablet | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 💬 |
748 | Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 💬 |
749 | Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 💬 |
750 | Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 💬 |
751 | Sodiumchloride | - | - | - | - | [1] 67 67 💬 |
752 | Sofosbuvir | [1] Sofosbuvir Sofosbuvir | [1] Sofosbuvir
Sofosbuvir
💬 | - | - | [1] 19 19 💬 |
753 | Softacort | - | - | - | - | [1] 53 53 💬 |
754 | Sogroya | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬 |
755 | Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬 |
756 | Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬 |
757 | SOL-116 | - | - | - | - | [1] 46 46 💬 |
758 | Solaris | - | - | - | - | [2] 62 62, 109 💬 |
759 | Solid food-based intervention | - | - | - | - | [1] 96 96 💬 |
760 | Solifenacin | [1] Solifenacin Solifenacin | [1] Solifenacin
Solifenacin
💬 | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [3] 6 6, 13, 53 💬 |
761 | Solifenacin Succinate | [1] Solifenacin Solifenacin | [1] Solifenacin
Solifenacin
💬 | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 💬 |
762 | Solifenacin Succinate (VESIcare) | [1] Solifenacin Solifenacin | [1] Solifenacin
Solifenacin
💬 | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 6 6 💬 |
763 | SOLIGEN | - | - | - | - | [1] 6 6 💬 |
764 | SOLIRIS | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 💬 |
765 | Soliris (eculizumab) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
766 | Soliris (R) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬 |
767 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 13 13, 62, 109 💬 |
768 | Soliris 300 | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
769 | SOLIRIS 300 mg concentrado para solución para perfusión | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 109 109 💬 |
770 | Soliris 300 mg concentrate for solution for infusion | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
771 | Soliris 300mg/30ml | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
772 | Soliris ™ (eculizumab) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
773 | Soliris® | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
774 | SOLIRIS® (eculizumab) injection, for intravenous use | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬 |
775 | Solondo | - | - | - | - | [1] 222 222 💬 |
776 | SOLU MEDROL | - | - | - | - | [1] 56 56 💬 |
777 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 💬 |
778 | SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML | - | - | - | - | [1] 56 56 💬 |
779 | SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML | - | - | - | - | [1] 56 56 💬 |
780 | Solu-Cortef | [3] Hydrocortisone Hydrocortisone, Hydrocortisone cypionate, Hydrocortisone succinate | [3] Hydrocortisone
Hydrocortisone
,
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 81, 83 💬 |
781 | Solu-Cortef (hydrocortisone) | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬 |
782 | Solu-Cortef 100 MG Injection | [3] Hydrocortisone Hydrocortisone, Hydrocortisone cypionate, Hydrocortisone succinate | [3] Hydrocortisone
Hydrocortisone
,
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬 |
783 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | [3] Hydrocortisone Hydrocortisone, Hydrocortisone cypionate, Hydrocortisone succinate | [3] Hydrocortisone
Hydrocortisone
,
Hydrocortisone cypionate
,
Hydrocortisone succinate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬 |
784 | Solu-Medrol | [2] Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone hemisuccinate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 49, 50, 51, 53, 97, 211 💬 |
785 | Solu-medrol inj. PSO LQF 40mg | [1] Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | [1] Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinate
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 50 50 💬 |
786 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 💬 |
787 | Solu-Medrone 125mg | - | - | - | - | [1] 46 46 💬 |
788 | Solu-Medrone 2 Gram | - | - | - | - | [1] 46 46 💬 |
789 | Solu-Medrone 2mg | - | - | - | - | [1] 46 46 💬 |
790 | SOLU-MODERIN 1 g | - | - | - | - | [1] 13 13 💬 |
791 | Soluble Fc receptor | - | - | - | - | [1] 49 49 💬 |
792 | Soluble Fc-gamma receptor IIb | - | - | - | - | [1] 49 49 💬 |
793 | Soluble fiber supplementation | - | - | - | - | [1] 299 299 💬 |
794 | SOLUBLE PREDNISOLONE TABLETS | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 💬 |
795 | Soluble Ve cadherin | - | - | - | - | [1] 51 51 💬 |
796 | Solucion de Cloruro de Sodio | - | - | - | - | [1] 228 228 💬 |
797 | Solucion de cloruro de sodio Sodium Chloride Solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 228 228 💬 |
798 | SoluMedrol | - | - | - | - | [1] 13 13 💬 |
799 | Solumedrol IM 125mg/2ml | - | - | - | - | [1] 13 13 💬 |
800 | Solution de chlorhydrate de dopamine anaérobie | [1] Dopamine Dopamine | [1] Dopamine
Dopamine
💬 | [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
801 | Soluzione di levodopa/carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬 | [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
802 | Solvente Cloruro de Sodio Sodium Chloride Solvent | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 228 228 💬 |
803 | Solvente de Cloruro de Sodio | - | - | - | - | [1] 228 228 💬 |
804 | SOM0226 | - | - | - | - | [1] 28 28 💬 |
805 | SOM230 | - | - | - | - | [2] 74 74, 75 💬 |
806 | SOM230 300µg | - | - | - | - | [1] 75 75 💬 |
807 | SOM230 600µg | - | - | - | - | [1] 75 75 💬 |
808 | SOM230 900µg | - | - | - | - | [1] 75 75 💬 |
809 | SOM230 LAR | - | - | - | - | [1] 75 75 💬 |
810 | SOM230 LAR 10 mg | - | - | - | - | [1] 75 75 💬 |
811 | SOM230 LAR 30 mg | - | - | - | - | [1] 75 75 💬 |
812 | SOM230 LAR, 20 mg | - | - | - | - | [1] 75 75 💬 |
813 | SOM230 s.c. | - | - | - | - | [1] 75 75 💬 |
814 | SOM230, 300micrograms | - | - | - | - | [1] 75 75 💬 |
815 | SOM230, 600 micrograms | - | - | - | - | [1] 75 75 💬 |
816 | SOM230, 900 micrograms | - | - | - | - | [1] 75 75 💬 |
817 | SOM230B | - | - | - | - | [1] 75 75 💬 |
818 | SOM3355 | - | - | - | - | [1] 8 8 💬 |
819 | SOM3355 (bevantolol hydrochloride) | [1] Bevantolol Bevantolol | - | - | - | [1] 8 8 💬 |
820 | SOM3355 100mg BID | - | - | - | - | [1] 8 8 💬 |
821 | SOM3355 200mg BID | - | - | - | - | [1] 8 8 💬 |
822 | SOM3355 capsules | - | - | - | - | [1] 8 8 💬 |
823 | Somalgen | - | - | - | - | [1] 299 299 💬 |
824 | SOMAPACITAN | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 78 78, 195 💬 |
825 | Somapacitan 10 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
826 | Somapacitan 10 mg/1.5ml PDS290S | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
827 | Somapacitan 15 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬 |
828 | Somapacitan 15 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
829 | Somapacitan 5 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬 |
830 | Somapacitan 5 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
831 | Somatic gene-therapy by X-CGD | - | - | - | - | [1] 65 65 💬 |
832 | SomatoKine/IPLEX | - | - | - | - | [1] 113 113 💬 |
833 | Somatorelin | [1] Somatorelin Somatorelin | [1] Somatorelin
Somatorelin
💬 | [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 78 💬 |
834 | Somatostatin | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬 | [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 78 💬 |
835 | Somatotropin | [1] Somatotropin Somatotropin | - | - | - | [4] 3 3, 65, 78, 236 💬 |
836 | Somatotropine | - | - | - | - | [1] 78 78 💬 |
837 | Somatrogon | [1] Somatrogon Somatrogon | [1] Somatrogon
Somatrogon
💬 | - | - | [1] 78 78 💬 |
838 | Somatrogon (Genetical Recombination) | [1] Somatrogon Somatrogon | [1] Somatrogon
Somatrogon
💬 | - | - | [1] 78 78 💬 |
839 | Somatropin | [1] Somatotropin Somatotropin | - | - | - | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬 |
840 | Somatropin (DNA origin) | [1] Somatotropin Somatotropin | - | - | - | [1] 19 19 💬 |
841 | Somatropin (INN) recombinant DNA orgin, Escherichia coli | [2] Escherichia coli Escherichia coli, Somatotropin | - | - | - | [1] 78 78 💬 |
842 | Somatropin (rDNA origin) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
843 | Somatropin (recombinant DNA origin produced in E. coli) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
844 | SOMATROPIN (recombinant DNA-derived human growth hormone) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
845 | Somatropin - adult cohort | [1] Somatotropin Somatotropin | - | - | - | [1] 193 193 💬 |
846 | Somatropin - GH naïve pediatric cohort | [1] Somatotropin Somatotropin | - | - | - | [1] 193 193 💬 |
847 | Somatropin - GH treated cohort | [1] Somatotropin Somatotropin | - | - | - | [1] 193 193 💬 |
848 | Somatropin [rDNA origin] for injection | [1] Somatotropin Somatotropin | - | - | - | [2] 46 46, 96 💬 |
849 | Somatropin AQ | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
850 | SOMATROPIN FOR INJECTION | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
851 | Somatropin Injection | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
852 | Somatropin(rhGH) | [1] Somatotropin Somatotropin | - | - | - | [1] 96 96 💬 |
853 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | [5] Arginine Arginine, Clonidine, Estradiol, Estradiol valerate, Somatotropin | [4] Estradiol
Estradiol
,
Clonidine
,
Estradiol valerate
,
Arginine
💬 | [5] ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬 |
854 | SOMATROPINA | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
855 | Somatropine | - | - | - | - | [1] 78 78 💬 |
856 | Somatuline | - | - | - | - | [2] 67 67, 298 💬 |
857 | Somatuline Autogel | [1] Lanreotide Lanreotide | - | - | - | [1] 67 67 💬 |
858 | Somatuline Autogel 90 mg | [1] Lanreotide Lanreotide | - | - | - | [1] 298 298 💬 |
859 | Somatuline Autosolution | - | - | - | - | [1] 67 67 💬 |
860 | Somavaratan | [1] Somavaratan Somavaratan | [1] Somavaratan
Somavaratan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
861 | Somavaratan (VRS-317) | [1] Somavaratan Somavaratan | [1] Somavaratan
Somavaratan
💬 | [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 💬 |
862 | Sonlicromanol | [1] Sonlicromanol Sonlicromanol | - | - | - | [1] 21 21 💬 |
863 | SonoVue | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬 | - | - | [1] 96 96 💬 |
864 | Sorafenib | [1] Sorafenib Sorafenib | [1] Sorafenib
Sorafenib
💬 | [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [2] 34 34, 86 💬 |
865 | Sorafenib (as tosylate) | [1] Sorafenib Sorafenib | [1] Sorafenib
Sorafenib
💬 | [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬 |
866 | SORAPRAZAN | - | - | - | - | [1] 301 301 💬 |
867 | Sorbitol | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬 | - | - | [1] 10 10 💬 |
868 | SORBITOLO | - | - | - | - | [1] 10 10 💬 |
869 | Sortis | - | - | - | - | [1] 93 93 💬 |
870 | Sortis 10 mg | - | - | - | - | [1] 93 93 💬 |
871 | SOTATERCEPT | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬 | [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [2] 86 86, 284 💬 |
872 | Sotatercept - 45 mg/vial | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬 | [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬 |
873 | Sotatercept - 60 mg/vial | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬 | [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬 |
874 | Sotatercept with prednisone boost | [2] Prednisone Prednisone, Sotatercept | [2] Prednisone
Prednisone
,
Sotatercept
💬 | [2] ACVR2A ACVR2A, NR3C1 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 284 284 💬 |
875 | SOTICLESTAT | [1] Soticlestat Soticlestat | [1] Soticlestat
Soticlestat
💬 | [1] CYP46A1 CYP46A1 💬 | [1] Primary bile acid biosynthesis Primary bile acid biosynthesis 💬 | [2] 140 140, 144 💬 |
876 | Sotrastaurin | [1] Sotrastaurin Sotrastaurin | [1] Sotrastaurin
Sotrastaurin
💬 | [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬 | [29] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬 |
877 | Sotrastaurin (INN) acetate | [2] Acetate Acetate, Sotrastaurin | [1] Sotrastaurin
Sotrastaurin
💬 | [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬 | [29] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬 |
878 | Soy bread | - | - | - | - | [1] 298 298 💬 |
879 | Soy protein | - | - | - | - | [2] 6 6, 96 💬 |
880 | Soy protein isolate | - | - | - | - | [1] 227 227 💬 |
881 | Soya Bean oil | [1] Bean Bean | - | - | - | [1] 96 96 💬 |
882 | Soybean | [1] Soybean Soybean | - | - | - | [1] 97 97 💬 |
883 | SOYBEAN PHOSPHATIDYLCHOLINE | [2] Lecithin Lecithin, Soybean | [1] Lecithin
Lecithin
💬 | - | - | [1] 97 97 💬 |
884 | SPARC0921 | - | - | - | - | [1] 13 13 💬 |
885 | SPARSENTAN | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 66 66, 218, 222 💬 |
886 | Sparsentan compresse | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬 |
887 | Sparsentan tablets/ Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬 |
888 | Sparsentan tablets/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬 |
889 | Sparsentan tablets/over-encapsulated Spasenten tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬 |
890 | Sparsentan tablets/Overencapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬 |
891 | Sparsentan/Over-encapsulated Sparsentan tablet | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬 |
892 | Sparsentan/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬 | [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬 |
893 | SPD476 | - | - | - | - | [1] 97 97 💬 |
894 | SPD476 (mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
895 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬 | - | - | [1] 97 97 💬 |
896 | SPECT | - | - | - | - | [1] 6 6 💬 |
897 | SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM | [1] Ioflupane I-123 Ioflupane I-123 | - | - | - | [1] 2 2 💬 |
898 | Spesolilmab | - | - | - | - | [1] 96 96 💬 |
899 | Spesolimab | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬 | [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 37 37, 96, 97 💬 |
900 | Spesolimab IV infusion | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬 | [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬 |
901 | Spesolimab SC solution for injection | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬 | [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬 |
902 | SPH3127 | - | - | - | - | [1] 97 97 💬 |
903 | SPH3127 Tablets with Dose A | - | - | - | - | [1] 97 97 💬 |
904 | SPH3127 Tablets with Dose B | - | - | - | - | [1] 97 97 💬 |
905 | Spheramine | [1] Spheramine Spheramine | - | - | - | [1] 6 6 💬 |
906 | Spheramine (BAY86-5280) | [1] Spheramine Spheramine | - | - | - | [1] 6 6 💬 |
907 | Sphingomyelin | - | - | - | - | [1] 79 79 💬 |
908 | SPI-1005 Ebselen 200mg Capsule x1 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬 |
909 | SPI-1005 Ebselen 200mg Capsule x2 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬 |
910 | SPI-1005 Ebselen 200mg Capsule x3 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬 |
911 | SPI-62 | - | - | - | - | [1] 75 75 💬 |
912 | SPI-62 dose 2 | - | - | - | - | [1] 75 75 💬 |
913 | SPI-62 dose 3 | - | - | - | - | [1] 75 75 💬 |
914 | SPI-62 dose 4 | - | - | - | - | [1] 75 75 💬 |
915 | SPI-62 dose1 | - | - | - | - | [1] 75 75 💬 |
916 | SPIF | - | - | - | - | [1] 95 95 💬 |
917 | Spikevax | [1] Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | [1] Elasomeran
Elasomeran
💬 | - | - | [1] 13 13 💬 |
918 | Spinal tap | - | - | - | - | [1] 25 25 💬 |
919 | Spinraza | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
920 | Spiriva | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 💬 |
921 | Spiriva Respimat | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 💬 |
922 | Spiriva Respimat 2.5 mcg | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 💬 |
923 | Spiriva Respimat 2.5 microgram | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 💬 |
924 | Spiriva Respimat 2.5 microgram, solution for inhalation | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 💬 |
925 | Spirix | - | - | - | - | [1] 225 225 💬 |
926 | Spironolactone | [1] Spironolactone Spironolactone | [1] Spironolactone
Spironolactone
💬 | [1] NR3C2 NR3C2 💬 | [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [8] 46 46, 58, 67, 86, 113, 210, 218, 225 💬 |
927 | Spironolactone (drug) | [1] Spironolactone Spironolactone | [1] Spironolactone
Spironolactone
💬 | [1] NR3C2 NR3C2 💬 | [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 210 210 💬 |
928 | Spironolactone and conivaptan | [2] Conivaptan Conivaptan, Spironolactone | [2] Spironolactone
Spironolactone
,
Conivaptan
💬 | [3] AVPR1A AVPR1A, AVPR2, NR3C2 💬 | [6] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬 |
929 | Spironolactone captopril carvedilol | [3] Captopril Captopril, Carvedilol, Spironolactone | [3] Captopril
Captopril
,
Carvedilol
,
Spironolactone
💬 | [7] ACE ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 | [19] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬 |
930 | Spiropent | - | - | - | - | [2] 6 6, 13 💬 |
931 | SPK-3006 | - | - | - | - | [1] 256 256 💬 |
932 | SPM 926 | - | - | - | - | [1] 6 6 💬 |
933 | SPM 962 | - | - | - | - | [1] 6 6 💬 |
934 | SPM927 | - | - | - | - | [1] 149 149 💬 |
935 | SPM962 | - | - | - | - | [1] 6 6 💬 |
936 | Sporanox | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬 | - | - | [2] 227 227, 299 💬 |
937 | Sporanox 10 mg/ml Oral Solution | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬 | - | - | [1] 299 299 💬 |
938 | SPP-004 | - | - | - | - | [1] 21 21 💬 |
939 | SPR001 | - | - | - | - | [1] 81 81 💬 |
940 | SPT3162 | - | - | - | - | [1] 145 145 💬 |
941 | Sputum | - | - | - | - | [1] 299 299 💬 |
942 | SPX-101 | - | - | - | - | [1] 299 299 💬 |
943 | SQ Fludarabine | [1] Fludarabine Fludarabine | [1] Fludarabine
Fludarabine
💬 | [1] RRM1 RRM1 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 49 49 💬 |
944 | SQJZ herbal mixtures | - | - | - | - | [1] 6 6 💬 |
945 | SR-fampridine | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬 |
946 | SR121463B | - | - | - | - | [1] 72 72 💬 |
947 | SR140333B | - | - | - | - | [1] 97 97 💬 |
948 | SR57667B | - | - | - | - | [1] 6 6 💬 |
949 | SRK-015 | - | - | - | - | [1] 3 3 💬 |
950 | Srolimus | - | - | - | - | [1] 89 89 💬 |
951 | SRP-4045 | - | - | - | - | [1] 113 113 💬 |
952 | SRP-4053 | - | - | - | - | [1] 113 113 💬 |
953 | SRP-5051 | - | - | - | - | [1] 113 113 💬 |
954 | SRP-9001 | - | - | - | - | [1] 113 113 💬 |
955 | SRP-9003 | [1] SRP-9003 SRP-9003 | - | - | - | [1] 113 113 💬 |
956 | SRP-9004 | - | - | - | - | [1] 113 113 💬 |
957 | SRT2104 | - | - | - | - | [1] 97 97 💬 |
958 | SRX246 | - | - | - | - | [1] 8 8 💬 |
959 | SS-1 | - | - | - | - | [1] 53 53 💬 |
960 | SS-20 | - | - | - | - | [1] 8 8 💬 |
961 | Ss-Adrenergic cocktail | - | - | - | - | [1] 299 299 💬 |
962 | Ss-hydroxybuturate esters | - | - | - | - | [1] 256 256 💬 |
963 | Ss-interferon | - | - | - | - | [1] 13 13 💬 |
964 | Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [1] Cysteamine
Cysteamine
💬 | - | - | [1] 19 19 💬 |
965 | SSGJ-613 | - | - | - | - | [1] 107 107 💬 |
966 | SSP-004184 100 mg | - | - | - | - | [1] 284 284 💬 |
967 | SSP-004184 100 mg Capsule | - | - | - | - | [1] 284 284 💬 |
968 | SSP-004184 250 mg | - | - | - | - | [1] 284 284 💬 |
969 | SSP-004184 250 mg Capsule | - | - | - | - | [1] 284 284 💬 |
970 | SSP-004184 375 mg | - | - | - | - | [1] 284 284 💬 |
971 | SSP-004184 375 mg Capsule | - | - | - | - | [1] 284 284 💬 |
972 | SSP-004184 50 mg | - | - | - | - | [1] 284 284 💬 |
973 | SSP-004184 50 mg Capsule | - | - | - | - | [1] 284 284 💬 |
974 | SSP-004184 500 mg | - | - | - | - | [1] 284 284 💬 |
975 | SSP-004184 500 mg Capsule | - | - | - | - | [1] 284 284 💬 |
976 | SSP-004184AQ 100 mg | - | - | - | - | [1] 284 284 💬 |
977 | SSP-004184AQ 100 mg Capsule | - | - | - | - | [1] 284 284 💬 |
978 | SSP-004184AQ 200 mg | - | - | - | - | [1] 284 284 💬 |
979 | SSP-004184AQ 200 mg Capsule | - | - | - | - | [1] 284 284 💬 |
980 | SSP-004184AQ 250 mg | - | - | - | - | [1] 284 284 💬 |
981 | SSP-004184AQ 250 mg Capsule | - | - | - | - | [1] 284 284 💬 |
982 | SSP-004184AQ 375 mg | - | - | - | - | [1] 284 284 💬 |
983 | SSP-004184AQ 375 mg Capsule | - | - | - | - | [1] 284 284 💬 |
984 | SSP-004184AQ 50 mg | - | - | - | - | [1] 284 284 💬 |
985 | SSP-004184AQ 50 mg Capsule | - | - | - | - | [1] 284 284 💬 |
986 | SSR150106 | - | - | - | - | [1] 46 46 💬 |
987 | SSR150106XB | - | - | - | - | [1] 46 46 💬 |
988 | SSZ | - | - | - | - | [1] 271 271 💬 |
989 | ST 261 | - | - | - | - | [1] 97 97 💬 |
990 | ST 36 | - | - | - | - | [1] 49 49 💬 |
991 | ST-0529 | - | - | - | - | [1] 97 97 💬 |
992 | ST-920 | - | - | - | - | [1] 19 19 💬 |
993 | ST10 | - | - | - | - | [1] 96 96 💬 |
994 | ST10-021 | - | - | - | - | [2] 96 96, 97 💬 |
995 | ST200 | - | - | - | - | [1] 265 265 💬 |
996 | ST261 | - | - | - | - | [1] 97 97 💬 |
997 | ST36 | - | - | - | - | [1] 6 6 💬 |
998 | STA 5326 mesylate | - | - | - | - | [1] 46 46 💬 |
999 | STA-5326 | - | - | - | - | [2] 65 65, 96 💬 |
1000 | STA-5326 mesylate | - | - | - | - | [1] 96 96 💬 |
1001 | STA-6838, STA-5326 m, S38 | - | - | - | - | [1] 96 96 💬 |
1002 | Stable isotope infusions | - | - | - | - | [1] 96 96 💬 |
1003 | Stable weekly dose of methotrexate | [1] Methotrexate Methotrexate | [1] Methotrexate
Methotrexate
💬 | [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 💬 |
1004 | Stalevo | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1005 | Stalevo (levodopa/ carbidopa/ entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1006 | Stalevo (levodopa/carbidopa/entacapona) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1007 | Stalevo (levodopa/carbidopa/entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1008 | Stalevo 100 | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1009 | Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1010 | Stalevo 100 mg/25 mg / 200 mg | - | - | - | - | [1] 6 6 💬 |
1011 | Stalevo 100/25/200 mg | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1012 | Stalevo 150 | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1013 | Stalevo 150/37.5/200 mg | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1014 | STALEVO*100CPR 100/25/200MG | [2] Entacapone Entacapone, Levodopa | [2] Levodopa
Levodopa
,
Entacapone
💬 | [6] COMT COMT, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Steroid hormone biosynthesis, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1015 | STALEVO*100CPR 50/12,5/200MG | [2] Entacapone Entacapone, Levodopa | [2] Levodopa
Levodopa
,
Entacapone
💬 | [6] COMT COMT, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Steroid hormone biosynthesis, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1016 | Stalevo® | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬 | [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1017 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 💬 |
1018 | Standard analgesia use [Fentanyl] | [1] Fentanyl Fentanyl | [1] Fentanyl
Fentanyl
💬 | [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬 |
1019 | Standard analgesia use [Hydromorphone] | [1] Hydromorphone Hydromorphone | [1] Hydromorphone
Hydromorphone
💬 | [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬 |
1020 | Standard analgesia use [Oxygen] | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬 | - | - | [1] 70 70 💬 |
1021 | Standard analgesia use [Volatile Anesthesia] | - | - | - | - | [1] 70 70 💬 |
1022 | Standard Care | - | - | - | - | [2] 81 81, 299 💬 |
1023 | Standard care Hyaluronic acid eye drops | [1] Hyaluronic acid Hyaluronic acid | [1] Hyaluronic acid
Hyaluronic acid
💬 | - | - | [1] 53 53 💬 |
1024 | Standard continuous antiretroviral therapy | - | - | - | - | [1] 265 265 💬 |
1025 | Standard DMARDs (Disease Modifying Anti Rheumatic Drugs) | - | - | - | - | [1] 46 46 💬 |
1026 | Standard dose of HCQ | - | - | - | - | [1] 49 49 💬 |
1027 | Standard dose of rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬 |
1028 | Standard Dose YPT-01 | - | - | - | - | [1] 299 299 💬 |
1029 | Standard Formula | - | - | - | - | [1] 299 299 💬 |
1030 | Standard formula (Enfamil) | - | - | - | - | [1] 299 299 💬 |
1031 | Standard gadolinium contrast | [1] Gadolinium Gadolinium | - | - | - | [1] 13 13 💬 |
1032 | Standard glucocorticoid therapy | - | - | - | - | [1] 81 81 💬 |
1033 | Standard interval dosing | - | - | - | - | [1] 13 13 💬 |
1034 | Standard LD/CD | - | - | - | - | [1] 6 6 💬 |
1035 | Standard MS DMT | - | - | - | - | [1] 13 13 💬 |
1036 | Standard MS DMTs | - | - | - | - | [1] 13 13 💬 |
1037 | Standard Nutritional Supplement + PERT | - | - | - | - | [1] 299 299 💬 |
1038 | Standard of Care | - | - | - | - | [8] 6 6, 13, 49, 51, 63, 64, 79, 171 💬 |
1039 | Standard of Care (SoC) | - | - | - | - | [1] 85 85 💬 |
1040 | Standard of Care Chemotherapy | - | - | - | - | [1] 28 28 💬 |
1041 | Standard of Care for Haemophilia A | - | - | - | - | [1] 288 288 💬 |
1042 | Standard of Care FVIII Replacement therapy | - | - | - | - | [1] 288 288 💬 |
1043 | Standard of care IV antibiotic(s) | - | - | - | - | [1] 299 299 💬 |
1044 | Standard of Care Medications | - | - | - | - | [1] 171 171 💬 |
1045 | Standard of care therapy | - | - | - | - | [1] 28 28 💬 |
1046 | Standard of Care Treatment | - | - | - | - | [3] 53 53, 245, 246 💬 |
1047 | Standard of Care: UDCA | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬 | [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬 |
1048 | Standard Plasma | - | - | - | - | [1] 64 64 💬 |
1049 | Standard step-up care | - | - | - | - | [1] 96 96 💬 |
1050 | Standard Steroid Treatment | - | - | - | - | [1] 85 85 💬 |
1051 | Standard therapy | - | - | - | - | [2] 49 49, 97 💬 |
1052 | Standard therapy (Excluding Immunosuppressants) | - | - | - | - | [1] 49 49 💬 |
1053 | Standard therapy (Including Immunosuppressants) | - | - | - | - | [1] 49 49 💬 |
1054 | Standard therapy (without eltrombopag): HD-DXM | [1] Eltrombopag Eltrombopag | - | - | - | [1] 63 63 💬 |
1055 | Standard therapy of septic shock | - | - | - | - | [1] 60 60 💬 |
1056 | Standard treatment with a conventional drug | - | - | - | - | [1] 13 13 💬 |
1057 | Standard Vitamin D3 Supplementation | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 60 60 💬 |
1058 | Standard-dose vitamin D (400IU per day) | [1] Vitamin D Vitamin D | - | - | - | [1] 274 274 💬 |
1059 | Standard-of-care treatment | - | - | - | - | [1] 49 49 💬 |
1060 | Standardized anthocyanin-rich extract | - | - | - | - | [1] 97 97 💬 |
1061 | Standardized cannabis extract | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 💬 |
1062 | Standardized FODMAP | - | - | - | - | [1] 97 97 💬 |
1063 | Standardized Ginkgo Biloba Extract (EGb 761 (r) | [1] Ginkgo biloba Ginkgo biloba | - | - | - | [1] 18 18 💬 |
1064 | Standardized turmeric root extract | [1] Turmeric Turmeric | - | - | - | [1] 299 299 💬 |
1065 | Standart of care | - | - | - | - | [1] 96 96 💬 |
1066 | Standrd of Care treatment | - | - | - | - | [1] 64 64 💬 |
1067 | Stanozolol | [1] Stanozolol Stanozolol | [1] Stanozolol
Stanozolol
💬 | [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 60 60 💬 |
1068 | STAPHYLOCOCCAL PROTEIN A | [1] Bevifimod Bevifimod | - | - | - | [1] 63 63 💬 |
1069 | StarGen | - | - | - | - | [1] 301 301 💬 |
1070 | Start adalimumab in monotherapy | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
1071 | Stasis | [1] Ferric sulfate Ferric sulfate | [1] Ferric sulfate
Ferric sulfate
💬 | - | - | [2] 66 66, 97 💬 |
1072 | Statin | - | - | - | - | [1] 13 13 💬 |
1073 | Statins | - | - | - | - | [2] 46 46, 79 💬 |
1074 | Stavudine | [1] Stavudine Stavudine | [1] Stavudine
Stavudine
💬 | - | - | [1] 265 265 💬 |
1075 | Stelara | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 56, 96, 97, 269, 271 💬 |
1076 | Stelara (ustekinumab) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 65 65 💬 |
1077 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1078 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1079 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬 |
1080 | STELARA 130 mg concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1081 | Stelara 130mg / 26mL concentrate for solution for | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1082 | Stelara 130mg / 26mL concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1083 | STELARA 90 mg solution for injection in pre-filled syringe | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1084 | Stelara 90mg/1ml solution for injecti | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1085 | Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1086 | Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra | [3] Infliximab Infliximab, Ustekinumab, Vedolizumab | [3] Infliximab
Infliximab
,
Vedolizumab
,
Ustekinumab
💬 | [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬 |
1087 | STELARA® | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [3] 49 49, 96, 97 💬 |
1088 | STELARA¿ | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬 |
1089 | Stem Cell | - | - | - | - | [2] 2 2, 113 💬 |
1090 | Stem cell (HPC) implantation | - | - | - | - | [1] 2 2 💬 |
1091 | Stem cell implantation | - | - | - | - | [1] 90 90 💬 |
1092 | Stem cell therapy | - | - | - | - | [1] 5 5 💬 |
1093 | Stem Cell Transplant | - | - | - | - | [2] 60 60, 65 💬 |
1094 | Stem Cell Transplantation | - | - | - | - | [10] 13 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
1095 | Stem Cells | - | - | - | - | [5] 2 2, 4, 46, 96, 113 💬 |
1096 | STEM-PD | - | - | - | - | [1] 6 6 💬 |
1097 | Stem/progenitor cells transplantation | - | - | - | - | [2] 90 90, 301 💬 |
1098 | Stempeucel(R) | - | - | - | - | [1] 47 47 💬 |
1099 | StemRegen product | - | - | - | - | [1] 6 6 💬 |
1100 | Step-up | - | - | - | - | [1] 96 96 💬 |
1101 | Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [2] 62 62, 254 💬 |
1102 | STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V) | - | - | - | - | [1] 299 299 💬 |
1103 | Sterile saline | - | - | - | - | [1] 227 227 💬 |
1104 | Sterile saline for injection | - | - | - | - | [1] 97 97 💬 |
1105 | Sterile saline solution | - | - | - | - | [1] 51 51 💬 |
1106 | Sterile Water for Injection | [1] Water Water | [1] Water
Water
💬 | - | - | [1] 78 78 💬 |
1107 | Steroid | - | - | - | - | [2] 107 107, 288 💬 |
1108 | Steroid & Cyclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬 | [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬 |
1109 | Steroid and Proton Pump Inhibitor Therapy | - | - | - | - | [1] 98 98 💬 |
1110 | Steroid Drug | - | - | - | - | [2] 46 46, 49 💬 |
1111 | Steroid injections | - | - | - | - | [1] 70 70 💬 |
1112 | Steroid Taper | - | - | - | - | [1] 49 49 💬 |
1113 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬 |
1114 | Steroids plus azathioprine | [1] Azathioprine Azathioprine | [1] Azathioprine
Azathioprine
💬 | - | - | [1] 66 66 💬 |
1115 | STG-001 | [1] STG-001 STG-001 | - | - | - | [1] 301 301 💬 |
1116 | STI-6129 | - | - | - | - | [1] 28 28 💬 |
1117 | STI571 | - | - | - | - | [2] 51 51, 86 💬 |
1118 | Stilnoct | - | - | - | - | [1] 6 6 💬 |
1119 | Stiripentol | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬 | - | - | [1] 140 140 💬 |
1120 | Stiripentolo | - | - | - | - | [1] 140 140 💬 |
1121 | STK-001 | [1] Zorevunersen Zorevunersen | - | - | - | [1] 140 140 💬 |
1122 | STK-001 - Multiple Ascending Doses | [1] Zorevunersen Zorevunersen | - | - | - | [1] 140 140 💬 |
1123 | STK-001 - Single Ascending Doses | [1] Zorevunersen Zorevunersen | - | - | - | [1] 140 140 💬 |
1124 | STNF-R1 | [1] Pegsunercept Pegsunercept | [1] Pegsunercept
Pegsunercept
💬 | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬 |
1125 | STNM01 | - | - | - | - | [1] 97 97 💬 |
1126 | STNM01 1.84 mg | - | - | - | - | [1] 97 97 💬 |
1127 | Stood sample | - | - | - | - | [1] 49 49 💬 |
1128 | Stool analysis | - | - | - | - | [1] 46 46 💬 |
1129 | Stools | - | - | - | - | [1] 46 46 💬 |
1130 | STOP arm | - | - | - | - | [1] 84 84 💬 |
1131 | Strattera | - | - | - | - | [1] 6 6 💬 |
1132 | Strensiq | [1] Asfotase alfa Asfotase alfa | [1] Asfotase alfa
Asfotase alfa
💬 | [1] ALPL ALPL 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | [1] 172 172 💬 |
1133 | STRIMVELIS | - | - | - | - | [1] 65 65 💬 |
1134 | Stromal Vascular fraction | - | - | - | - | [1] 51 51 💬 |
1135 | Stromal vascular fraction (SVF) | - | - | - | - | [1] 96 96 💬 |
1136 | Strontium ranelate | [1] Strontium ranelate Strontium ranelate | [1] Strontium ranelate
Strontium ranelate
💬 | - | - | [1] 78 78 💬 |
1137 | STS | - | - | - | - | [2] 50 50, 51 💬 |
1138 | Study Drug | - | - | - | - | [2] 6 6, 13 💬 |
1139 | Study medication, azithromycin | [1] Azithromycin Azithromycin | [2] Azithromycin
Azithromycin
,
Azithromycin
💬 | - | - | [1] 299 299 💬 |
1140 | Study of the gene expression profile | - | - | - | - | [1] 51 51 💬 |
1141 | Study treatment PPI | - | - | - | - | [1] 166 166 💬 |
1142 | STW5-II | - | - | - | - | [1] 97 97 💬 |
1143 | STW5-II (Iberogast N, BAY98-7410) | - | - | - | - | [1] 97 97 💬 |
1144 | STX107 | - | - | - | - | [1] 206 206 💬 |
1145 | STX209 | - | - | - | - | [1] 206 206 💬 |
1146 | Sub-Study: Nintedanib | [1] Nintedanib Nintedanib | [1] Nintedanib
Nintedanib
💬 | [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬 |
1147 | Sub-Study: Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬 | [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬 |
1148 | SUB0750MIG | - | - | - | - | [1] 13 13 💬 |
1149 | SUB08293MIG | - | - | - | - | [1] 222 222 💬 |
1150 | SUB09246MIG | - | - | - | - | [1] 18 18 💬 |
1151 | SUB126308 | - | - | - | - | [1] 2 2 💬 |
1152 | SUB16402MIG | - | - | - | - | [1] 227 227 💬 |
1153 | SUB175614 | - | - | - | - | [1] 13 13 💬 |
1154 | SUB180983 | - | - | - | - | [1] 107 107 💬 |
1155 | SUB185183 | - | - | - | - | [1] 299 299 💬 |
1156 | SUB195712 | - | - | - | - | [1] 19 19 💬 |
1157 | SUB20016 | - | - | - | - | [1] 96 96 💬 |
1158 | SUB21605 | - | - | - | - | [1] 225 225 💬 |
1159 | SUB21634 | - | - | - | - | [1] 235 235 💬 |
1160 | SUB22282 | - | - | - | - | [1] 13 13 💬 |
1161 | Subcutaneous (SC) Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬 |
1162 | Subcutaneous Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬 |
1163 | Subcutaneous and intravenous prostacyclin | [1] Epoprostenol Epoprostenol | [1] Epoprostenol
Epoprostenol
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
1164 | Subcutaneous apomorphine | [1] Apomorphine Apomorphine | [1] Apomorphine
Apomorphine
💬 | [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1165 | Subcutaneous Beloranib in Suspension | [1] Beloranib Beloranib | - | - | - | [1] 193 193 💬 |
1166 | Subcutaneous hydrocortisone 10mg | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬 |
1167 | Subcutaneous immune globulin G | - | - | - | - | [1] 14 14 💬 |
1168 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 💬 |
1169 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬 |
1170 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬 |
1171 | Subcutaneous tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬 |
1172 | Subcutaneous tocilizumab 162mg/biweekly | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬 | [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬 |
1173 | Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [1] Treprostinil
Treprostinil
💬 | [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬 |
1174 | Subcutaneous Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬 | [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 56 56 💬 |
1175 | Subcutaneous(SC) Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬 | [2] CD80 CD80, CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬 |
1176 | Subcutanious administration | - | - | - | - | [1] 46 46 💬 |
1177 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 💬 |
1178 | Subgam | - | - | - | - | [1] 65 65 💬 |
1179 | Subjects will undergo the 123-I IBVM imaging visit | - | - | - | - | [1] 6 6 💬 |
1180 | Sublimated mare milk | - | - | - | - | [1] 93 93 💬 |
1181 | Sublingual nitroglycerine | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬 | - | - | [1] 46 46 💬 |
1182 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [1] Tizanidine
Tizanidine
💬 | [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬 |
1183 | Submucosal Bevacizumab | [1] Bevacizumab Bevacizumab | [1] Bevacizumab
Bevacizumab
💬 | [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 227 227 💬 |
1184 | Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus | - | - | - | - | [1] 90 90 💬 |
1185 | Subretinal injection of rAAV.hPDE6A | - | - | - | - | [1] 90 90 💬 |
1186 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | [1] 90 90 💬 |
1187 | Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes | - | - | - | - | [1] 90 90 💬 |
1188 | Subtenon injection of Wharton jelly derived mesenchymal stem cells | - | - | - | - | [1] 90 90 💬 |
1189 | Sucralfate | [1] Sucralfate Sucralfate | [1] Sucralfate
Sucralfate
💬 | - | - | [1] 98 98 💬 |
1190 | Sucrose | [1] Sucrose Sucrose | [1] Sucrose
Sucrose
💬 | - | - | [3] 62 62, 96, 97 💬 |
1191 | Sucrosomial Iron | [1] Iron Iron | - | - | - | [1] 97 97 💬 |
1192 | Sufentanil | [1] Sufentanil Sufentanil | [1] Sufentanil
Sufentanil
💬 | [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [2] 70 70, 280 💬 |
1193 | Sugar Extract | - | - | - | - | [2] 96 96, 97 💬 |
1194 | Sugar pill | - | - | - | - | [8] 5 5, 6, 49, 67, 70, 86, 206, 210 💬 |
1195 | Sulfadoxine | [1] Sulfadoxine Sulfadoxine | [1] Sulfadoxine
Sulfadoxine
💬 | - | - | [1] 65 65 💬 |
1196 | SULFAMETH | - | - | - | - | [1] 60 60 💬 |
1197 | Sulfamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] Sulfamethoxazole
Sulfamethoxazole
💬 | - | - | [5] 44 44, 49, 61, 85, 299 💬 |
1198 | SULFASALAZINE | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬 | - | - | [6] 46 46, 86, 94, 107, 270, 271 💬 |
1199 | Sulfasalazine + Hydroxychloroquine | [2] Hydroxychloroquine Hydroxychloroquine, Sulfasalazine | [2] Sulfasalazine
Sulfasalazine
,
Hydroxychloroquine
💬 | - | - | [1] 46 46 💬 |
1200 | Sulfasalazine, SSZ | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬 | - | - | [1] 271 271 💬 |
1201 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬 |
1202 | Sulfate d'hydroxychloroquine | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] Hydroxychloroquine
Hydroxychloroquine
💬 | - | - | [1] 53 53 💬 |
1203 | Sulfate, Magnesium | [2] Magnesium Magnesium, Sulfate ion | - | - | - | [1] 64 64 💬 |
1204 | Sulfato de amikacina | [1] Amikacin Amikacin | [1] Amikacin
Amikacin
💬 | - | - | [1] 299 299 💬 |
1205 | Sulforaphane | [1] Sulforaphane Sulforaphane | - | - | - | [2] 6 6, 205 💬 |
1206 | Sulfotanshinone Sodium Injection | - | - | - | - | [1] 224 224 💬 |
1207 | Sulfur Colloid | [1] Gelatin Gelatin | [2] Gelatin
Gelatin
,
Donkey glue
💬 | - | - | [1] 299 299 💬 |
1208 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬 | - | - | [2] 96 96, 215 💬 |
1209 | Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬 | - | - | [1] 215 215 💬 |
1210 | Sulindac | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬 |
1211 | Sulindac (HLX-0201), dose strength 1 | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬 |
1212 | Sulindac (HLX-0201), dose strength 2 | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬 |
1213 | Sulphamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] Sulfamethoxazole
Sulfamethoxazole
💬 | - | - | [1] 85 85 💬 |
1214 | Sulphasalazine | - | - | - | - | [2] 46 46, 271 💬 |
1215 | Sulphasalazine (SSZ) | - | - | - | - | [1] 271 271 💬 |
1216 | Sulphasalazine 500 mg En-Tabs | - | - | - | - | [1] 271 271 💬 |
1217 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | [1] 97 97 💬 |
1218 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬 | - | - | [1] 96 96 💬 |
1219 | Sumanirole | [1] Sumanirole Sumanirole | - | - | - | [1] 6 6 💬 |
1220 | Sunflower oil | [1] Sunflower oil Sunflower oil | [1] Sunflower oil
Sunflower oil
💬 | - | - | [2] 46 46, 299 💬 |
1221 | Sunitinib | [1] Sunitinib Sunitinib | [1] Sunitinib
Sunitinib
💬 | [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [36] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 28 28, 34 💬 |
1222 | Sunitinib malate | [1] Sunitinib Sunitinib | [1] Sunitinib
Sunitinib
💬 | [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [36] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 28 28 💬 |
1223 | SUNPG1622 I dose | - | - | - | - | [1] 271 271 💬 |
1224 | Sunphenon | - | - | - | - | [2] 13 13, 113 💬 |
1225 | Sunphenon EGCG | [1] Epigallocatechin gallate Epigallocatechin gallate | - | - | - | [3] 13 13, 17, 113 💬 |
1226 | Sunphenon EGCg TM | - | - | - | - | [1] 13 13 💬 |
1227 | Suplatast tosilate | - | - | - | - | [1] 226 226 💬 |
1228 | Supplement nutritional supporting | - | - | - | - | [1] 291 291 💬 |
1229 | Supplementation with vitamin D2/D3 | [1] Ergocalciferol Ergocalciferol | [1] Ergocalciferol
Ergocalciferol
💬 | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 💬 |
1230 | Supportive and immunosuppressive therapy | - | - | - | - | [1] 66 66 💬 |
1231 | Supportive therapy | - | - | - | - | [1] 66 66 💬 |
1232 | Supportive therapy with: ACE-inhibitor / ARB / Statin | - | - | - | - | [1] 66 66 💬 |
1233 | Supressi. T-Diet plus Range | - | - | - | - | [1] 6 6 💬 |
1234 | Suramin | [1] Suramin Suramin | - | - | - | [1] 331 331 💬 |
1235 | Surgical ESPB | - | - | - | - | [1] 70 70 💬 |
1236 | Surgical infusion of AAV-GAD into the subthalamic nucleus | - | - | - | - | [1] 6 6 💬 |
1237 | Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide | - | - | - | - | [1] 3 3 💬 |
1238 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬 |
1239 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬 |
1240 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬 |
1241 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬 |
1242 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1] 97 97 💬 |
1243 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬 |
1244 | Suspension de microbiote fécal | - | - | - | - | [1] 97 97 💬 |
1245 | Suspension IR | - | - | - | - | [1] 46 46 💬 |
1246 | Suspension media | - | - | - | - | [1] 13 13 💬 |
1247 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬 |
1248 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [1] 96 96 💬 |
1249 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 💬 |
1250 | Suspension of human autologous MSC 3P in 1,5 ml | - | - | - | - | [1] 2 2 💬 |
1251 | Suspension of human autologous MSC 3P in 1.5 ml | - | - | - | - | [1] 2 2 💬 |
1252 | Sustained release growth hormone | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
1253 | Sustained-release oral dalfampridine | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬 |
1254 | Sustained-release recombinant human GH (SR-rhGH) | [1] Somatotropin Somatotropin | - | - | - | [1] 78 78 💬 |
1255 | Sustanon | - | - | - | - | [1] 113 113 💬 |
1256 | Sustanon (testosterone) | [1] Testosterone Testosterone | [1] Testosterone
Testosterone
💬 | [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 113 113 💬 |
1257 | Sustanon 250 | - | - | - | - | [1] 113 113 💬 |
1258 | SUSTIVA | [1] Efavirenz Efavirenz | [1] Efavirenz
Efavirenz
💬 | - | - | [1] 265 265 💬 |
1259 | Sutent®/Sunitinib | [1] Sunitinib Sunitinib | [1] Sunitinib
Sunitinib
💬 | [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [36] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 34 34 💬 |
1260 | Sutimlimab | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬 | [1] C1S C1S 💬 | [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬 |
1261 | Sutimlimab (BIVV009) | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬 | [1] C1S C1S 💬 | [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬 |
1262 | Suvecaltamide | - | - | - | - | [1] 6 6 💬 |
1263 | Suvodirsen | - | - | - | - | [1] 113 113 💬 |
1264 | Suvorexant | [1] Suvorexant Suvorexant | [1] Suvorexant
Suvorexant
💬 | [2] HCRTR1 HCRTR1, HCRTR2 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 5 5, 6, 13 💬 |
1265 | SVS20 | - | - | - | - | [1] 53 53 💬 |
1266 | Swallowed fluticasone | [1] Fluticasone Fluticasone | [1] Fluticasone
Fluticasone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬 |
1267 | Sweet polvilho | - | - | - | - | [1] 257 257 💬 |
1268 | Switch to Myfortic | [1] Mycophenolic acid Mycophenolic acid | [1] Mycophenolic acid
Mycophenolic acid
💬 | [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 49 49 💬 |
1269 | SXR1096 | - | - | - | - | [1] 160 160 💬 |
1270 | Symbicort | - | - | - | - | [2] 85 85, 228 💬 |
1271 | Symbiotic Formula with DHA and antioxidants | - | - | - | - | [1] 299 299 💬 |
1272 | Symdeko | [2] Ivacaftor Ivacaftor, Tezacaftor | [2] Ivacaftor
Ivacaftor
,
Tezacaftor
💬 | [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬 |
1273 | Symdeko/Trikafta | [3] Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | [3] Ivacaftor
Ivacaftor
,
Tezacaftor
,
Elexacaftor
💬 | [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬 |
1274 | Symkevi | [2] Ivacaftor Ivacaftor, Tezacaftor | [2] Ivacaftor
Ivacaftor
,
Tezacaftor
💬 | [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬 |
1275 | Symkevi 100mg/150mg Film-coated tablets | [2] Ivacaftor Ivacaftor, Tezacaftor | [2] Ivacaftor
Ivacaftor
,
Tezacaftor
💬 | [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬 |
1276 | Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | [3] Aldosterone Aldosterone, Angiotensin II, Calcium | [3] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Aldosterone
💬 | [3] AGTR1 AGTR1, AGTR2, NR3C2 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬 |
1277 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 💬 |
1278 | SYN115 | - | - | - | - | [1] 6 6 💬 |
1279 | SYN115 Tablets, 60 mg | - | - | - | - | [1] 6 6 💬 |
1280 | SYN120 | - | - | - | - | [1] 6 6 💬 |
1281 | Synacthen | - | - | - | - | [1] 78 78 💬 |
1282 | Synacthen (Tetracosactrin) | [1] Tetracosactide Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 78 78 💬 |
1283 | Synacthen Ampoules 250 mcg | - | - | - | - | [1] 113 113 💬 |
1284 | Synacthen Ampoules 250 microgrammi | - | - | - | - | [1] 113 113 💬 |
1285 | Synacthen Depot | [1] Tetracosactide Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 83 83, 145, 222 💬 |
1286 | Synacthen Depot 1mg | [1] Tetracosactide Tetracosactide | [1] Cosyntropin
Cosyntropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 222 222 💬 |
1287 | SYNB1020 | - | - | - | - | [1] 251 251 💬 |
1288 | SYNB1353 | - | - | - | - | [1] 337 337 💬 |
1289 | SYNB1618 | - | - | - | - | [1] 240 240 💬 |
1290 | SYNB1934 | - | - | - | - | [1] 240 240 💬 |
1291 | Synbiotic | - | - | - | - | [1] 96 96 💬 |
1292 | Synbiotic (Synergy I / B.longum) | - | - | - | - | [1] 96 96 💬 |
1293 | Synergy | - | - | - | - | [1] 240 240 💬 |
1294 | Synergy-1 | - | - | - | - | [1] 97 97 💬 |
1295 | Synergy1 | - | - | - | - | [1] 97 97 💬 |
1296 | Synovial biopsy | - | - | - | - | [1] 46 46 💬 |
1297 | Synrinse | - | - | - | - | [1] 299 299 💬 |
1298 | SYNT001 | - | - | - | - | [1] 61 61 💬 |
1299 | Synthetic 15-amino-acid macrocyclic peptide | - | - | - | - | [1] 62 62 💬 |
1300 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 | - | - | - | - | [1] 62 62 💬 |
1301 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker | - | - | - | - | [1] 62 62 💬 |
1302 | Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker | - | - | - | - | [1] 62 62 💬 |
1303 | Synthetic DMARD(s) | - | - | - | - | [1] 46 46 💬 |
1304 | Synthetic Human Parathyroid Hormone 1-34 | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬 | [2] PTH1R PTH1R, PTH2R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬 |
1305 | Synthetic human secretin | [1] Secretin human Secretin human | - | - | - | [1] 298 298 💬 |
1306 | Synthetic Oxytocin | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬 | [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1307 | Synthetic PreImplantation Factor | [1] Preimplantation factor Preimplantation factor | - | - | - | [1] 95 95 💬 |
1308 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | [2] 2 2, 127 💬 |
1309 | Syntocinon | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬 | [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [3] 6 6, 127, 193 💬 |
1310 | Syntocinon 40 IU/ml nasal spray | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬 | [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬 |
1311 | Syntocinon nasal spray | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬 | [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬 |
1312 | Syntocinon®/- Spray | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬 | [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬 |
1313 | Syntropin | - | - | - | - | [1] 78 78 💬 |
1314 | Systane Ultra UD | - | - | - | - | [1] 53 53 💬 |
1315 | Systematic chemotherapy and antibodies | - | - | - | - | [1] 62 62 💬 |
1316 | Systemic anticoagulation | - | - | - | - | [1] 88 88 💬 |
1317 | Systemic chemotherapy and antibodies | - | - | - | - | [2] 62 62, 326 💬 |
1318 | Systemic non-biological treatments | - | - | - | - | [2] 46 46, 271 💬 |
1319 | Sübetaholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬 |
1320 | Süßholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬 |